California Legislature · 2017-2018 Regular Session
Chaptered
AB 265
Prescription drugs: prohibition on price discount.
Author:
Jim Wood
(D-AD02)
Show 1 co-author
David Chiu
(D-AD17)
Latest action:
Chaptered
(Oct 9, 2017)
Chapter 611, Statutes of 2017
Version history
11 versions — latest: Chaptered (Oct 9, 2017)
- Oct 9, 2017 Chaptered leginfo →
- Sep 15, 2017 Enrolled leginfo →
- Sep 7, 2017 Amended Senate leginfo →
- Aug 31, 2017 Amended Senate leginfo →
- Jun 27, 2017 Amended Senate leginfo →
- Jun 22, 2017 Amended Senate leginfo →
- May 30, 2017 Amended Assembly leginfo →
- May 10, 2017 Amended Assembly leginfo →
- Apr 26, 2017 Amended Assembly leginfo →
- Mar 27, 2017 Amended Assembly leginfo →
- Jan 31, 2017 Introduced leginfo →
Action history
-
Jan 31, 2017 Read first time. To print. Assembly
-
Feb 1, 2017 From printer. May be heard in committee March 3. Assembly
-
Feb 13, 2017 Referred to Com. on HEALTH. Assembly
-
Mar 9, 2017 Coauthors revised. Assembly
-
Mar 27, 2017 From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. Assembly
-
Mar 28, 2017 Re-referred to Com. on HEALTH. Assembly
-
Apr 25, 2017 From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 2.) (April 18). Assembly
-
Apr 26, 2017 Read second time and amended. Assembly
-
Apr 27, 2017 Re-referred to Com. on APPR. Assembly
-
May 10, 2017 From committee chair, with author's amendments: Amend, and re-refer to Com. on APPR. Read second time and amended. Assembly
-
May 11, 2017 Re-referred to Com. on APPR. Assembly
-
May 17, 2017 In committee: Set, first hearing. Referred to APPR. suspense file. Assembly
-
May 26, 2017 From committee: Amend, and do pass as amended. (Ayes 11. Noes 4.) (May 26). Assembly
-
May 30, 2017 Read second time. Ordered to third reading. Assembly
-
May 30, 2017 Assembly Rule 63 suspended. (Ayes 52. Noes 24. Page 1776.) Assembly
-
May 30, 2017 Read second time and amended. Ordered returned to second reading. Assembly
-
May 31, 2017 Read third time. Passed. Ordered to the Senate. (Ayes 51. Noes 15. Page 1960.) Assembly
-
Jun 1, 2017 In Senate. Read first time. To Com. on RLS. for assignment. Senate
-
Jun 14, 2017 Referred to Com. on HEALTH. Senate
-
Jun 22, 2017 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. Senate
-
Jun 26, 2017 In committee: Set, first hearing. Hearing canceled at the request of author. Senate
-
Jun 27, 2017 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. Senate
-
Jul 6, 2017 From committee: Do pass. (Ayes 7. Noes 2.) (July 5). Senate
-
Jul 10, 2017 Read second time. Ordered to third reading. Senate
-
Aug 31, 2017 Read third time and amended. Ordered to second reading. Senate
-
Sep 1, 2017 Read second time. Ordered to third reading. Senate
-
Sep 7, 2017 Read third time and amended. Ordered to second reading. Senate
-
Sep 11, 2017 Read second time. Ordered to third reading. Senate
-
Sep 12, 2017 Read third time. Passed. Ordered to the Assembly. (Ayes 23. Noes 15. Page 2771.). Senate
-
Sep 13, 2017 Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 51. Noes 17. Page 3333.). Assembly
-
Sep 13, 2017 Assembly Rule 77(a) suspended. (Ayes 54. Noes 25. Page 3255.) Assembly
-
Sep 13, 2017 In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 15 pursuant to Assembly Rule 77. Assembly
-
Sep 20, 2017 Enrolled and presented to the Governor at 4:30 p.m. Governor
-
Oct 9, 2017 Approved by the Governor. Governor
-
Oct 9, 2017 Chaptered by Secretary of State - Chapter 611, Statutes of 2017. Secretary of State
Votes recorded
3 votes
Sep 13, 2017 · Assembly Floor
AB 265 Wood Concurrence in Senate Amendments
Tally
51
·
17
·
11
PASS
Democrat
47/0/6
Republican
3/17/5
Other
1/0/0
Aye
(51)
Cecilia Aguiar-Curry
(D-AD04)
Joaquin Arambula
(D-AD31)
Richard Bloom
(D-AD50)
Raul Bocanegra
(D-AD39)
Rob Bonta
(D-AD18)
Autumn Burke
(D-AD62)
Anna Caballero
(D-AD30)
Ian Charles Calderon
(D-AD57)
Sabrina Cervantes
(D-AD60)
Ed Chau
(D-AD49)
David Chiu
(D-AD17)
Kansen Chu
(D-AD25)
Ken Cooley
(D-AD08)
Cristina Garcia
(D-AD58)
Matthew Dababneh
(D-AD45)
Tom Daly
(D-AD69)
Eduardo Garcia
(D-AD56)
Susan Talamantes Eggman
(D-AD13)
Laura Friedman
(D-AD43)
Mike Gipson
(D-AD64)
Adam Gray
(D-AD21)
Timothy Grayson
(D-AD14)
Chris Holden
(D-AD41)
Jacqui Irwin
(D-AD44)
Reginald Byron Jones-Sawyer
(D-AD59)
Ash Kalra
(D-AD27)
Marc Levine
(D-AD10)
Monique Limón
(D-AD37)
Evan Low
(D-AD28)
Mark Stone
(D-AD29)
Kevin McCarty
(D-AD07)
Jose Medina
(D-AD61)
Al Muratsuchi
(D-AD66)
Adrin Nazarian
(D-AD46)
Patrick O'Donnell
(D-AD70)
Bill Quirk
(D-AD20)
Sharon Quirk-Silva
(D-AD65)
Anthony Rendon
(D-AD63)
Eloise Gómez Reyes
(D-AD47)
Freddie Rodriguez
(D-AD52)
Blanca Rubio
(D-AD48)
Rudy Salas
(D-AD32)
Miguel Santiago
(D-AD53)
Tony Thurmond
(D-AD15)
Philip Ting
(D-AD19)
Shirley Weber
(D-AD79)
Jim Wood
(D-AD02)
Dante Acosta
(R-AD38)
Brian Dahle
(R-AD01)
James Gallagher
(R-AD03)
Gonzalez Fletcher
No
(17)
Catharine Baker
(R-AD16)
William Brough
(R-AD73)
Rocky Chávez
(R-AD76)
Phillip Chen
(R-AD55)
Steven Choi
(R-AD68)
Jordan Cunningham
(R-AD35)
Heath Flora
(R-AD12)
Matthew Harper
(R-AD74)
Kevin Kiley
(R-AD06)
Tom Lackey
(R-AD36)
Devon Mathis
(R-AD26)
Melissa Melendez
(R-AD67)
Jay Obernolte
(R-AD33)
Jim Patterson
(R-AD23)
Marc Steinorth
(R-AD40)
Travis Allen
(R-AD72)
Randy Voepel
(R-AD71)
Abstain / Other
(11)
Marc Berman
(D-AD24)
Jim Cooper
(D-AD09)
Jim Frazier
(D-AD11)
Todd Gloria
(D-AD78)
Kevin Mullin
(D-AD22)
Sebastian Ridley-Thomas
(D-AD54)
Franklin Bigelow
(R-AD05)
Vince Fong
(R-AD34)
Brian Maienschein
(R-AD77)
Chad Mayes
(R-AD42)
Marie Waldron
(R-AD75)
Sep 12, 2017 · Senate Floor
Assembly 3rd Reading AB265 Wood et al. By Hernandez
Tally
23
·
15
·
2
PASS
Democrat
23/2/2
Republican
0/13/0
Other
0/0/0
Aye
(23)
Benjamin Allen
(D-SD26)
Toni Atkins
(D-SD39)
Jim Beall
(D-SD15)
Steven Bradford
(D-SD35)
Kevin De León
(D-SD24)
Bill Dodd
(D-SD03)
Cathleen Galgiani
(D-SD05)
Ed Hernandez
(D-SD22)
Robert Hertzberg
(D-SD18)
Ben Hueso
(D-SD40)
Hannah-Beth Jackson
(D-SD19)
Ricardo Lara
(D-SD33)
Connie Leyva
(D-SD20)
Mike McGuire
(D-SD02)
Tony Mendoza
(D-SD32)
Holly Mitchell
(D-SD30)
Bill Monning
(D-SD17)
Josh Newman
(D-SD29)
Anthony Portantino
(D-SD25)
Nancy Skinner
(D-SD09)
Henry Stern
(D-SD27)
Bob Wieckowski
(D-SD10)
Scott Wiener
(D-SD11)
No
(15)
Steven Glazer
(D-SD07)
Jerry Hill
(D-SD13)
Joel Anderson
(R-SD38)
Patricia Bates
(R-SD36)
Tom Berryhill
(R-SD08)
Anthony Cannella
(R-SD12)
Jean Fuller
(R-SD16)
Ted Gaines
(R-SD01)
John Moorlach
(R-SD37)
Mike Morrell
(R-SD23)
Janet Nguyen
(R-SD34)
Jim Nielsen
(R-SD04)
Jeff Stone
(R-SD28)
Andy Vidak
(R-SD14)
Scott Wilk
(R-SD21)
Abstain / Other
(2)
Richard Pan
(D-SD06)
Richard Roth
(D-SD31)
May 31, 2017 · Assembly Floor
AB 265 WOOD Assembly Third Reading
Tally
51
·
15
·
11
PASS
Democrat
45/1/8
Republican
5/14/6
Other
1/0/0
Aye
(51)
Cecilia Aguiar-Curry
(D-AD04)
Joaquin Arambula
(D-AD31)
Richard Bloom
(D-AD50)
Raul Bocanegra
(D-AD39)
Rob Bonta
(D-AD18)
Autumn Burke
(D-AD62)
Anna Caballero
(D-AD30)
Ian Charles Calderon
(D-AD57)
Sabrina Cervantes
(D-AD60)
Ed Chau
(D-AD49)
David Chiu
(D-AD17)
Kansen Chu
(D-AD25)
Ken Cooley
(D-AD08)
Cristina Garcia
(D-AD58)
Matthew Dababneh
(D-AD45)
Tom Daly
(D-AD69)
Eduardo Garcia
(D-AD56)
Laura Friedman
(D-AD43)
Mike Gipson
(D-AD64)
Jimmy Gomez
(D-AD51)
Chris Holden
(D-AD41)
Jacqui Irwin
(D-AD44)
Reginald Byron Jones-Sawyer
(D-AD59)
Ash Kalra
(D-AD27)
Marc Levine
(D-AD10)
Monique Limón
(D-AD37)
Evan Low
(D-AD28)
Mark Stone
(D-AD29)
Kevin McCarty
(D-AD07)
Jose Medina
(D-AD61)
Al Muratsuchi
(D-AD66)
Adrin Nazarian
(D-AD46)
Patrick O'Donnell
(D-AD70)
Bill Quirk
(D-AD20)
Sharon Quirk-Silva
(D-AD65)
Anthony Rendon
(D-AD63)
Eloise Gómez Reyes
(D-AD47)
Freddie Rodriguez
(D-AD52)
Blanca Rubio
(D-AD48)
Rudy Salas
(D-AD32)
Miguel Santiago
(D-AD53)
Tony Thurmond
(D-AD15)
Philip Ting
(D-AD19)
Shirley Weber
(D-AD79)
Jim Wood
(D-AD02)
Dante Acosta
(R-AD38)
Brian Dahle
(R-AD01)
James Gallagher
(R-AD03)
Matthew Harper
(R-AD74)
Devon Mathis
(R-AD26)
Gonzalez Fletcher
No
(15)
Adam Gray
(D-AD21)
Catharine Baker
(R-AD16)
Franklin Bigelow
(R-AD05)
William Brough
(R-AD73)
Rocky Chávez
(R-AD76)
Jordan Cunningham
(R-AD35)
Heath Flora
(R-AD12)
Kevin Kiley
(R-AD06)
Tom Lackey
(R-AD36)
Jay Obernolte
(R-AD33)
Jim Patterson
(R-AD23)
Marc Steinorth
(R-AD40)
Travis Allen
(R-AD72)
Randy Voepel
(R-AD71)
Marie Waldron
(R-AD75)
Abstain / Other
(14)
Marc Berman
(D-AD24)
Jim Cooper
(D-AD09)
Susan Talamantes Eggman
(D-AD13)
Jim Frazier
(D-AD11)
Todd Gloria
(D-AD78)
Timothy Grayson
(D-AD14)
Kevin Mullin
(D-AD22)
Sebastian Ridley-Thomas
(D-AD54)
Phillip Chen
(R-AD55)
Steven Choi
(R-AD68)
Vince Fong
(R-AD34)
Brian Maienschein
(R-AD77)
Chad Mayes
(R-AD42)
Melissa Melendez
(R-AD67)
Lobbying activity
FPPC lobbying disclosures whose activity descriptions mention AB 265, scoped to filings whose coverage period extends through or beyond this bill's introduction date.
Note: CalAccess lobby filings reference bills by measure number only — no session tag. When the same measure number has existed in earlier sessions (e.g. a previously chaptered bill still being lobbied on for implementation), some of those filings may appear here even though they relate to a different bill. Use the activity descriptions to disambiguate.
| Period | Form | Filer | Firm / Employer | Lobbying Activity | Filing |
|---|---|---|---|---|---|
| 04/01/2018–06/30/2018 | Employer Report | ASTRA ZENECA PHARMACEUTICALS, LP | — | Legislature: SB790; asthma and oncology issues; diabetes and cardiovascular health issues; Budget re CDPH long-range asthma plan; AB265 implementation; OSHPD: SB17 implementation; CalRecycle: SB486 Implementation. | #2270069 |
| 01/01/2018–03/31/2018 | Employer Report | ASTRA ZENECA PHARMACEUTICALS, LP | — | Legislature: SB790, diabetes and cardiovascular health issues; Budget re CDPH long-range asthma plan; AB265 implementation; OSHPD: SB17 implementation. | #2241366 |
| 01/01/2018–03/31/2018 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512, 1751, 1752, 1753, 1963, 1998, 2174, 2256, 2384, 2486, 2487, 2741, 2760, 2789, 2804, 2859, 2861 and SB 17, 212, 443, 1103, 1109, 1229, 1240 and Opioid Abuse Policy and ePrescribing legislation | #2237362 |
| 10/01/2017–12/31/2017 | Employer Report | American Federation of State, County and Municipal Employees California People | American Federation of State, County and Municipal Employees California People | AB 156, 157, 180, 205, 207, 265, 391, 595, 1240, 1258, 1353; SB 17, 133, 134, 152, 171, 199, 202, 220, 223, 349, 487, 562, 575, 762; Governor, Covered California: health reform; Dept. of Health Care Services: Medical Interpreter and Medi-Cal. | #2211321 |
| 10/01/2017–12/31/2017 | Employer Report | Blue Shield of California | Blue Shield of California | AB: 156, 205, 224, 265, 340, 391, 447, 1048, 1074, 1092, 1316; SB: 17, 33, 133, 171, 223, 294, 374, 538, 562; California Department of Healthcare Services, California Department of Managed Healthcare, California Health and Human Services Agency : Specialty Drugs, Medi-Cal, 3rd Party Payments | #2212043 |
| 10/01/2017–12/31/2017 | Employer Report | CALIFORNIA ACADEMY OF FAMILY PHYSICIANS | CALIFORNIA ACADEMY OF FAMILY PHYSICIANS | AB 40, AB 247, AB 265, AB 340, AB 443, AB 447, AB 461, AB 841, AB 1002, AB 1048, AB 1316, AB 1340; SB 17, SB 54, SB 223, SB 294, SB 396, SB 437, SB 536, SB 554, SB 796, SB 798; SR 37 -- Governor | #2207330 |
| 10/01/2017–12/31/2017 | Employer Report | CALIFORNIA ASSOCIATION OF HEALTH UNDERWRITERS | CALIFORNIA ASSOCIATION OF HEALTH UNDERWRITERS | AB 156, 205, 211, 251, 265, 447, 989, 1107, 1140, 1534, 1601; SB 17, 172, 374, 538, 562, 581, 788; Covered California, Department of Insurance re: grandfathered plans | #2209243 |
| 10/01/2017–12/31/2017 | Employer Report | CALIFORNIA PODIATRIC MEDICAL ASSOCIATION | CALIFORNIA PODIATRIC MEDICAL ASSOCIATION (CPMA) | AB 265, 715, 1153; SB 17, 241, 554, 798 | #2209233 |
| 10/01/2017–12/31/2017 | Employer Report | California Professional Firefighters | California Professional Firefighters | AB 20, 44, 46, 55, 61, 199, 249, 265, 450, 512, 530, 568, 570, 722, 725, 848, 890, 901, 978, 1116, 1120, 1157, 1194, 1410, 1455, 1479, 1646, 1650; SB 17, 33, 45, 63, 133, 226, 231, 285, 302, 306, 334, 432, 443, 450, 550, 649, 687 | #2208411 |
| 10/01/2017–12/31/2017 | Employer Report | CELGENE CORPORATION | Celgene | AB 265; SB 17, 212, 790 | #2209496 |
| 10/01/2017–12/31/2017 | Employer Report | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | INSPERITY SERVICES, L.P. | AB 265; SB 17 | #2209482 |
| 10/01/2017–12/31/2017 | Employer Report | HEALTH NET COMPANIES & CA HEALTH AND WELLNESS, WHOLLY OWNED SUBSIDIARIES OF CENTENE, INC | HEALTH NET COMPANIES AND CALIFORNIA HEALTH AND WELLNESS | AB 1048, 1074, 1092, 1107, 1110, 113, 120, 1316, 15, 1534, 156, 157, 1601, 182, 205, 224, 251, 265, 29, 315, 391, 40, 417, 43, 447, 595, 97; SB 133, 134, 17, 171, 172, 191, 199, 221, 222, 223, 288, 294, 33, 374, 399, 456, 538, 562, 636, 647, 743, 753 | #2203201 |
| 10/01/2017–12/31/2017 | Employer Report | HEMOPHILIA COUNCIL OF CALIFORNIA | HEMOPHILIA COUNCIL OF CALIFORNIA | STATE BUDGET: MEDI-CAL CCS GHPP. CCS REDESIGN & WHOLE CHILD MODEL. PHARMACY ISSUE PER FEDERAL CMS RULING.SB 152 AB 613 SCR 33 AB 265AB 1250. | #2210634 |
| 10/01/2017–12/31/2017 | Employer Report | KALEO | — | Lobbied the Legislature regarding AB 265, opioid overdose and prevention. | #2206089 |
| 10/01/2017–12/31/2017 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 443 and Opioid Abuse Policy and ePrescribing legislation | #2208210 |
| 10/01/2017–12/31/2017 | Employer Report | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | AB 265; SB 17 | #2210543 |
| 10/01/2017–12/31/2017 | Employer Report | NOVARTIS SERVICES, INC | — | Governor's Office, Department of Health Care Services, Health and Human Services Agency Business, Consumer Services and Housing, Agency Department of Finance, CA Dept of Public Health, AB 265, SB 17 | #2207223 |
| 10/01/2017–12/31/2017 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 29, 40, 182, 186, 265, 315, 444, 587, 715, 904, 1048, 1107, 1353, 1368, 1512; ACR 14, 18; ACA 4; SB 17, 199, 212, 419, 562, 567, 641, 790 | #2211571 |
| 07/01/2017–09/30/2017 | Employer Report | AIDS HEALTHCARE FOUNDATION | — | Governor re: general HIV health issues. Governor and Legislature re: AB 265, SB 2, SB 17 and SB 35. Legislature re: AB 249, AB 511, AB 587, AB 1033, AB 1250, AB 1534 and SB 790. Healthcare Services and Legislature re: managed care rate. Public Health re: HIV testing pilot program. Industrial Relations re: Adult film worker safety. Legislature re: General housing access issues. | #2190012 |
| 07/01/2017–09/30/2017 | Employer Report | ALKERMES | — | Legislature: AB 182, AB 265, AB 532, SB 17, SB 790; STR Grant Implementation, Parity of Access for Medication Assisted Treatment | #2191968 |
| 07/01/2017–09/30/2017 | Employer Report | Allergan USA, Inc. | Allergn USA, Inc. | AB 265, 443; SB 510 | #2190953 |
| 07/01/2017–09/30/2017 | Employer Report | AMERICAN COLLEGE OF PHYSICIANS - CALIFORNIA CHAPTER | — | AB 148; 265; 1221; 1316; 1534 SB 17; 323; 396; 790; 798 | #2193336 |
| 07/01/2017–09/30/2017 | Employer Report | American Federation of State, County and Municipal Employees, AFL-CIO | American Federation of State, County and Municipal Employees, AFL-CIO | AB 10, 19, 44, 46, 83, 156, 164, 175, 205, 236, 242, 247, 265, 391, 432, 568, 569, 603, 621, 670, 676, 848, 1004, 1017, 1209, 1227, 1250, 1320, 1455, 1456, 1538, 1565; ACR 2, 9, 29, 31, 43, 46, 47, 95, 100, 104; AJR 11, 19; HR 43; SB 2, 17, 29, 31, 49, 54, 63, 133, 171, 199, 223, 231, 258, 285, 306, 318, 360, 432, 550, 570, 574, 575, 728, 731, 772, 789; SCA 12; SCR 66, SR 21. | #2192485 |
| 07/01/2017–09/30/2017 | Employer Report | American Federation of State, County and Municipal Employees California People | American Federation of State, County and Municipal Employees California People | AB 156, 157, 180, 205, 207, 265, 391, 595, 1240, 1258, 1353; SB 17, 133, 134, 152, 171, 199, 202, 220, 223, 349, 487, 562, 575, 762; Governor, Covered California: health reform. | #2193771 |
| 07/01/2017–09/30/2017 | Employer Report | AMERICAN G.I. FORUM OF CALIFORNIA | — | AB85, AB153, AB172, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1403, AB1618, AB1710, AB1711, ACR112, HR49, SB3, SB156, SB246, SB266, SB330, SB339, SB349, SB409, SB410, SB455, SB485, SB488, SB694, SB725, SB728, SB731, SB776, SCR55, SCR61, SCR65 | #2189205 |
| 07/01/2017–09/30/2017 | Employer Report | American Heart Association | American Heart Association | AB 99, 265, 623, 709, 725, 735, 746, 834 841, 1003, 1205; SB 5, 55, 133, 138, 210, 386, 623, 687, 760; Legislature: Tobacco-related legislation; California Board of Education: TUPE and Proposition 56 funding; State Auditor and Department of Justice: Proposition 56 funding and regulations. | #2192730 |
| 07/01/2017–09/30/2017 | Employer Report | AMERICAN LEGION, DEPARTMENT OF CALIFORNIA | — | AB85, AB153, AB172, AB226, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB376, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, AB1618, AB1710, AB1711, ACR112, HR49, SB3, SB156, SB246, SB266, SB330, SB339, SB349, SB409, SB410, SB485, SB488, SB694, SB725, SB728, SB731, SB776, SCR55, SCR65 | #2190757 |
| 07/01/2017–09/30/2017 | Employer Report | AMERICAN LUNG ASSOCIATION DBA AMERICAN LUNG ASSOCIATION IN CALIFORNIA | AMERICAN LUNG ASSOCIATION IN CALIFORNIA | CARB CEC CDTFA AG State Auditor GOV AB 32/SB 32 Implementation Prop 56 Implementation Budget Issues SB 5 SB 41 SB 49 SB 57 SB 100 SB 150 SB 254 SB 258 SB 386 SB 440 SB 498 SB 563 SB 719 SB 802 AB 62 AB 262 AB 265 AB 378 AB 391 AB 398 AB 402 AB 476 AB 511 AB 582 AB 617 AB 709 AB 725 AB 890 AB 1082 AB 1083 AB 1132 AB 1143 AB 1205 AB 1279 AB 1400 | #2193182 |
| 07/01/2017–09/30/2017 | Employer Report | AMERICAN NURSES ASSOCIATION/CALIFORNIA | CALIFORNIA NURSE MIDWIVES ASSOCIATION (CNMA) | AB 40, 44, 156, 164, 182, 186, 191, 224, 229, 254, 265, 401, 402, 422, 470, 569, 643, 836, 859, 1102, 1229, 1316, 1560; SB 17, 43, 133, 134, 169, 239, 294, 309, 349, 512, 554, 743, 799 | #2190455 |
| 07/01/2017–09/30/2017 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature re: Pharmaceutical Pricing, AB 40, 43, 182, 265, 315, 401, 444, 447, 587, 715, 1048, 1512, SB 17, 176, 315, 510, 641 | #2191806 |
| 07/01/2017–09/30/2017 | Employer Report | AMVETS, DEPARTMENT OF CALIFORNIA | — | AB85, AB153, AB172, AB226, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, AB1710, AB1711, ACR112, HR49, SB3, SB156, SB246, SB266, SB330, SB339, SB349, SB409, SB410, SB455, SB485, SB488, SB694, SB725, SB728, SB731, SB776, SCR55, SCR65 | #2190755 |
| 07/01/2017–09/30/2017 | Employer Report | ARTHRITIS FOUNDATION | — | AB 265 and Formulary Transparency at the California Department of Managed Health Care (SB 1052 - 14) | #2185992 |
| 07/01/2017–09/30/2017 | Employer Report | ASTELLAS PHARMA US, INC. | — | AB 265 AB 315 SB 17 SB 790 Department of Health & Human Services Re: SB 17 | #2190275 |
| 07/01/2017–09/30/2017 | Employer Report | ASTRA ZENECA PHARMACEUTICALS, LP | — | Legislature: AB265, SB17, SB790, diabetes and cardiovascular health issues | #2194137 |
| 07/01/2017–09/30/2017 | Employer Report | BAYER U.S. LLC | — | AB 265; SB 17; SB 790 | #2191622 |
| 07/01/2017–09/30/2017 | Employer Report | BIOCOM | — | Legislature: AB 182, AB 444, AB 602, SB 212, SB 790, SCA 7, SB 17, AB 265 Governor's office: AB 602, AB 265, SB 17, SB 790 | #2193964 |
| 07/01/2017–09/30/2017 | Employer Report | BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | Legislature: AB 265; SB 17; SB 790. | #2192296 |
| 07/01/2017–09/30/2017 | Employer Report | BOEHRINGER INGELHEIM | — | AB 265, 315, 447; SB 17, 790 | #2191056 |
| 07/01/2017–09/30/2017 | Employer Report | BRISTOL-MYERS SQUIBB COMPANY | — | Legislature: AB 265; SB 17, 790 | #2191593 |
| 07/01/2017–09/30/2017 | Employer Report | CALIFORNIA ACADEMY OF FAMILY PHYSICIANS | CALIFORNIA ACADEMY OF FAMILY PHYSICIANS | AB 40, 97, 148, 265, 315, 340, 443, 461, 508, 715, 841, 1002, 1048, 1316, 1340, 1368, 1560' SB 17, 54, 97, 223, 294, 374, 396, 437, 536, 554, 790, 796, 798; SR 37 -- Legislature. | #2191978 |
| 07/01/2017–09/30/2017 | Employer Report | CALIFORNIA ACADEMY OF PHYSICIAN ASSISTANTS | CALIFORNIA ACADEMY OF PHYSICIAN ASSISTANTS | AB 40, 265, 391, 447, 1048, 1316, 1368, 1510, 1534; SB 419, 554, 790 | #2190456 |
| 07/01/2017–09/30/2017 | Employer Report | CALIFORNIA ASSOCIATION OF HEALTH UNDERWRITERS | CALIFORNIA ASSOCIATION OF HEALTH UNDERWRITERS | AB 156, 205, 211, 251, 265, 447, 989, 1107, 1140, 1534, 1601; SB 17, 172, 374, 538, 562, 581, 788; Covered California, Department of Insurance re: grandfathered plans | #2189629 |
| 07/01/2017–09/30/2017 | Employer Report | CALIFORNIA CHRONIC CARE COALITION | — | Legislature: AB182, AB265, AB613, AB1250, SB17, SB133, SB374, SB349, SB790 | #2192071 |
| 07/01/2017–09/30/2017 | Employer Report | California-Hawaii State Conference of the NAACP | California-Hawaii State Conference of the NAACP | AB 5, 16, 23, 43, 185, 259, 265, 284, 406, 422, 535, 844, 1008, 1089, 1115, 1217, 1344, 1360, 1478, 1488, 1520, 1578; SB 8, 10, 17, 145, 163, 180, 185, 190, 277, 345, 349, 356, 393, 394, 395, 439, 450, 562, 574, 607, 784, 789, 808; SCA 12; HR 57; Hate Crime Audit. | #2194171 |
| 07/01/2017–09/30/2017 | Employer Report | CALIFORNIA PODIATRIC MEDICAL ASSOCIATION | CALIFORNIA PODIATRIC MEDICAL ASSOCIATION (CPMA) | AB 97, 186, 265, 508, 715, 1153; SB 17, 97, 241, 554, 798 | #2194201 |
| 07/01/2017–09/30/2017 | Employer Report | CALIFORNIA PUBLIC INTEREST RESEARCH GROUP | — | AB 587, AB 265, AB 315; SB 100; AB 1407; AB 1678; SB 17; AB 918; SB 727; SB 33; AB 249; SB 258; AB 375; SB 313; SB 1316; AB 1328; AB 587; SB 790 | #2192316 |
| 07/01/2017–09/30/2017 | Employer Report | CALIFORNIA RHEUMATOLOGY ALLIANCE | — | AB 1353, AB 265, AB 315, SB 790 | #2190624 |
| 07/01/2017–09/30/2017 | Employer Report | CALIFORNIA STATE COMMANDERS VETERANS COUNCIL | — | AB85, AB153, AB172, AB226, AB242, AB265, AB266, AB296, AB331, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB522, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, AB1618, AB1710, AB1711, ACR112, HR49, SB3, SB156, SB246, SB266, SB330, SB339, SB349, SB409, SB410, SB455, SB485, SB488, SB694, SB725, SB728, SB731, SB776, SCR55, SCR65 | #2189213 |
| 07/01/2017–09/30/2017 | Employer Report | CARDINAL HEALTH, INC. | — | AB 265, 401; SB 17, 790 | #2193184 |
| 07/01/2017–09/30/2017 | Employer Report | CELGENE CORPORATION | Celgene | AB 265; SB 17, 212, 790 | #2190463 |
| 07/01/2017–09/30/2017 | Employer Report | CONSUMER FEDERATION OF CALIFORNIA | — | AB 87, 103, 165, 168, 175, 243, 265, 314, 375, 380, 413, 502, 550, 611, 713, 726, 814, 853, 859, 889, 940, 965, 1054, 1056, 1070, 1108, 1185, 1255, 1429, 1127, 1526, 1575, 1679; SB 16, 17, 21, 33, 62, 63, 66, 71, 87 202, 219, 244, 300, 313, 520, 562, 566, 598, 641, 648, 649, Dept. of Insurance, Gov?s office. | #2204557 |
| 07/01/2017–09/30/2017 | Employer Report | Daiichi Sankyo Inc. | DAIICHI SANKYO | Legislature: AB 265; SB 17; SB 790. | #2191166 |
| 07/01/2017–09/30/2017 | Employer Report | ENDO | — | Legislature: AB265, AB315, AB715, SB17, SB790 | #2192082 |
| 07/01/2017–09/30/2017 | Employer Report | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | INSPERITY SERVICES, L.P. | AB 1, 36, 265, 315, 1386; SB 1, 17, 790 | #2193072 |
| 07/01/2017–09/30/2017 | Employer Report | GILEAD SCIENCES, INC. | GILEAD SCIENCES, INC. | AB 265; SB 790 | #2188412 |
| 07/01/2017–09/30/2017 | Employer Report | GLAXOSMITHKLINE | — | Legislature: AB265, AB315, AB444, SB17, SB212, SB790, SCR74, Affinity update and progress in HIV/AIDS data sharing with Medi-Cal health plans | #2192095 |
| 07/01/2017–09/30/2017 | Employer Report | Greenwich Biosciences, Inc. | Greenwich Biosciences, Inc. | AB 265, 845; SB 17 | #2193190 |
| 07/01/2017–09/30/2017 | Employer Report | GRIFOLS SHARED SERVICES NORTH AMERICA, INC. | — | Legislature: AB265, AB315, AB613, SB17, SB790: CDPH: Plasma Center Personnel | #2192105 |
| 07/01/2017–09/30/2017 | Employer Report | HEMOPHILIA COUNCIL OF CALIFORNIA | HEMOPHILIA COUNCIL OF CALIFORNIA | STATE BUDGET: MEDI-CAL CCS GHPP CCS REDESIGN MEDI-CAL PHARMACY ISSUES PER FEDERAL CMS RULING SB 152 AB 613 AB 265 SCR 33 AB 1250 | #2193943 |
| 07/01/2017–09/30/2017 | Employer Report | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | AB 265, 602, 906, 1668; SB 17, 258, 606, 790; SAFER CONSUMER PRODUCTS PROGRAM - DEPARTMENT OF TOXIC SUBSTANCES CONTROL; WATER QUALITY FEES, WATER CONSERVATION, INDUSTRIAL WATER USE, PROCESS WATER - STATE WATER RESOURCES CONTROL BOARD | #2193110 |
| 07/01/2017–09/30/2017 | Employer Report | KALEO | — | Lobbied the Legislature regarding AB 265 and SB 17. | #2188461 |
| 07/01/2017–09/30/2017 | Employer Report | MALLINCKRODT, LLC | — | AB 265, SB 17; SB 790 | #2191586 |
| 07/01/2017–09/30/2017 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 443 and Opioid Abuse Policy | #2193702 |
| 07/01/2017–09/30/2017 | Employer Report | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | MERCK & CO., INC. including MERCK HUMAN HEALTH DIVISION and MERCK MEDCO MANAGED CARE AND MEDCO CAL | AB 265; SB 17, 790 | #2191653 |
| 07/01/2017–09/30/2017 | Employer Report | MILITARY OFFICERS ASSOCIATION OF AMERICA, CALIFORNIA COUNCIL OF CHAPTERS | — | AB85, AB153, AB172, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, AB1618, AB1710, AB1711, ACR112, HR49, SB3, SB156, SB246, SB266, SB330, SB339, SB349, SB409, SB410, SB455, SB485, SB488, SB694, SB725, SB728, SB731, SB776, SCR55, SCR65 | #2189208 |
| 07/01/2017–09/30/2017 | Employer Report | NextGen Climate Action | NextGen Climate Action | AB 33, 38, 73, 90, 109, 134, 193, 214, 265, 378, 398, 617, 638, 678, 802, 1000, 1073, 1082, 1083, 1184, 1239, 1521, 1668, 1731; AJR 9; SB 2, 3, 5, 10, 17, 30, 31, 35, 49, 50, 51, 54, 63, 100, 167, 180, 231, 244, 250, 338, 424, 488, 498, 596, 606, 620, 623; Air Resources Board: Advanced Clean Truck Rule, Low Carbon Fuel Standard; Legislature: Puente Power Plant. | #2194252 |
| 07/01/2017–09/30/2017 | Employer Report | NOVARTIS SERVICES, INC | — | Governor's Office, Department of Health Care Services, Health and Human Services Agency Business, Consumer Services and Housing, Agency Department of Finance, CA Dept of Public Health, AB 265, SB 17, SB 790 | #2192058 |
| 07/01/2017–09/30/2017 | Employer Report | NOVO NORDISK, INC. | — | State legislature: AB 265; SB 17, 790. | #2192194 |
| 07/01/2017–09/30/2017 | Employer Report | OTSUKA AMERICA PHARMACEUTICAL, INC. | — | CALIFORNIA STATE LEGISLATURE REGARDING: AB 265, AB 350, AB 587, SB 8, SB 17, SB 212, SB 790 | #2191606 |
| 07/01/2017–09/30/2017 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 29, 40, 182, 186, 265, 315, 444, 587, 715, 904, 1048, 1107, 1353, 1368, 1512; ACR 14, 18; ACA 4; SB 17, 199, 212, 419, 562, 567, 641, 790 | #2192577 |
| 07/01/2017–09/30/2017 | Employer Report | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | MIDPENINSULA REGIONAL OPEN SPACE DISTRICT | AB 265, 315 | #2190081 |
| 07/01/2017–09/30/2017 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 17, 715; SB 17, 790, 212; AB 265, 315, 1512 | #2190332 |
| 07/01/2017–09/30/2017 | Employer Report | Plasma Protein Therapeutics Association | Plasma Protein Therapeutics Association | Bills lobbied: AB 265, AB 613, SB 17, SB 790. Department of Health Care Services - Outpatient Drug Reimbursement Rule - Blood Factors. | #2194404 |
| 07/01/2017–09/30/2017 | Employer Report | Sanofi US | Sanofi US | Legislature: AB 265; AB 315; AB 602; SB 17; SB 790. | #2192175 |
| 07/01/2017–09/30/2017 | Employer Report | SUNOVION PHARMACEUTICALS INC. | SUNOVION PHARMACEUTICALS INC. | Legislature: AB 265; AB 315; AB 444; AB 532; SB 17; SB 790 | #2193121 |
| 07/01/2017–09/30/2017 | Employer Report | TAKEDA PHARMACEUTICALS AMERICA | — | Legislature: AB 265, AB 315, SB 17, SB 562, SB 790 | #2191091 |
| 07/01/2017–09/30/2017 | Employer Report | UCB INC. | UCB INC. | Legislature: AB 265; SB 17; SB 790. Governor's Office: SB 17; AB 265. | #2191521 |
| 07/01/2017–09/30/2017 | Employer Report | VERTEX PHARMACEUTICALS INCORPORATED | — | Rare Diseases Legislature: AB 265, SB 17, SB 790 Governor's Office: AB 265, SB 17, SB 790 | #2191103 |
| 07/01/2017–09/30/2017 | Employer Report | VIETNAM VETERANS OF AMERICA, CALIFORNIA STATE COUNCIL | — | AB85, AB153, AB172, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB547, AB665, AB671, AB866, AB1106, AB1249, AB1269, AB1365, AB1403, AB1618, AB1710, AB1711, ACR112, HR49, SB3, SB156, SB246, SB266, SB330, SB339, SB349, SB409, SB410, SB485, SB694, SB725, SB728, SB731, SB776, SCR55, SCR65 | #2189221 |
| 04/01/2017–06/30/2017 | Employer Report | ABBVIE | ABBVIE | AB 265, 587, 1512; SB 17, 790 | #2175552 |
| 04/01/2017–06/30/2017 | Employer Report | Allergan USA, Inc. | Allergn USA, Inc. | AB 102, 265; SB 17, 510, 790 | #2169239 |
| 04/01/2017–06/30/2017 | Employer Report | AMERICAN COLLEGE OF PHYSICIANS - CALIFORNIA CHAPTER | — | AB 148; 265; 859; 1221; 1316; 1534 SB 17; 43; 176; 323; 396; 419; 481; 641; 790; 798 | #2175431 |
| 04/01/2017–06/30/2017 | Employer Report | American Federation of State, County and Municipal Employees California People | American Federation of State, County and Municipal Employees California People | AB 156,157,180,205,207,265,391,595,1240,1258,1353; SB 17,133,134,152,171,199,202,220,223,349, 487,562,575,762; Governor, Covered California: health reform. | #2174057 |
| 04/01/2017–06/30/2017 | Employer Report | AMERICAN LUNG ASSOCIATION IN CALIFORNIA | AMERICAN LUNG ASSOCIATION IN CALIFORNIA | CARB CEC BOE GOV AB 32/SB 32 Implementation Prop 56 Implementation Budget Issues SB 1 SB 41 SB 49 SB 57 SB 100 SB 254 SB 386 SB 440 SB 498 SB 563 SB 719 SB 802 AB 62 AB 262 AB 265 AB 378 AB 391 AB 402 AB 476 AB 511 AB 582 AB 709 AB 725 AB 1082 AB 1083 AB 1132 AB 1143 AB 1205 AB 1279 | #2176165 |
| 04/01/2017–06/30/2017 | Employer Report | AMERICAN NURSES ASSOCIATION/CALIFORNIA | CALIFORNIA NURSE MIDWIVES ASSOCIATION (CNMA) | AB 9, 10, 40, 44, 156, 164, 182, 186, 191, 223, 224, 229, 244, 254, 265, 286, 305, 387, 401, 402, 422, 470, 569, 643, 836, 859, 882, 992, 1102, 1240, 1258, 1316, 1560, 1612, 1650; HR 6; SB 17, 18, 23, 27, 43, 133, 134, 169, 172, 176, 245, 250, 294, 309, 320, 349, 457, 512, 554, 562, 743, 799; SR 26 | #2169928 |
| 04/01/2017–06/30/2017 | Employer Report | AMERICA'S HEALTH INSURANCE PLANS (AHIP) | AMERICA'S HEALTH INSURANCE PLANS | AB 29, 265, 315, 1107, 1316, 1353, 1534; SB 17, 172, 221, 223, 399, 538, 562 | #2174854 |
| 04/01/2017–06/30/2017 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature re: Pharmaceutical Pricing, AB 40, 43, 182, 265, 315, 444, 447, 587, 1048, 1512, 17, 176, 315, 510, 641 | #2173833 |
| 04/01/2017–06/30/2017 | Employer Report | AMGEN | AMGEN | Legislature: AB 265; AB 444; SB 17; SB 349; SB 790. | #2171628 |
| 04/01/2017–06/30/2017 | Employer Report | ARTHRITIS FOUNDATION | — | AB 1353 (prior authorization), AB 265 | #2178321 |
| 04/01/2017–06/30/2017 | Employer Report | ASTELLAS PHARMA US, INC. | — | SB 17, SB 790, AB 265, AB 315 | #2171047 |
| 04/01/2017–06/30/2017 | Employer Report | ASTRA ZENECA PHARMACEUTICALS, LP | — | Legislature: AB265, AB1107, SB17, SB790, Budget-Diabetes Prevention Program | #2173301 |
| 04/01/2017–06/30/2017 | Employer Report | BAYER U.S. LLC | — | AB 9; AB 265; AB 514; SB 17; SB 602; SB 790 | #2171587 |
| 04/01/2017–06/30/2017 | Employer Report | BIOCOM | — | SCA 7, AB 182, AB 600, SB 600, SB 790, AB 1512, SB 562, SB 567, AB 602, SB 327, SB 212, AB 444, Drugs & Sharps waste disposal , SB 17, AB 265 Administration: BIO convention in San Diego, AB 265, SB 17, SB 790 | #2176878 |
| 04/01/2017–06/30/2017 | Employer Report | BIOTECHNOLOGY INNOVATION ORGANIZATION | BIO (BIOTECHNOLOGY INDUSTRY ORGANIZATION) | Legislature: AB 265; SB 17; SB 790. | #2171326 |
| 04/01/2017–06/30/2017 | Employer Report | BOEHRINGER INGELHEIM | — | AB 265, 315, 447, 1349; SB 17, 66, 567, 790 | #2168561 |
| 04/01/2017–06/30/2017 | Employer Report | BRISTOL-MYERS SQUIBB COMPANY | — | Legislature: AB 265; SB 17, 790 | #2170045 |
| 04/01/2017–06/30/2017 | Employer Report | CALIFORNIA ASSOCIATION OF JOINT POWERS AUTHORITIES | CALIFORNIA ASSOCIATION OF JOINT POWERS AUTHORITIES | AB 44, 182, 221, 241, 265, 383, 568, 570, 670, 913, 989, 1008, 1024, 1028, 1029, 1140, 1250, 1295, 1298, 1548; SB 205, 210, 302, 467, 496, 524, 562, 577, 617, 632, 772; Department of Industrial Relations: Annual Employer Assessment Update | #2175001 |
| 04/01/2017–06/30/2017 | Employer Report | CALIFORNIA CHRONIC CARE COALITION | — | Legislature: AB154, AB182, AB265, AB532, AB1353, SB17, SB641, SB172, SB374, SB349, SB790, SB419 | #2174385 |
| 04/01/2017–06/30/2017 | Employer Report | CALIFORNIA SOCIETY OF DERMATOLOGY & DERMATOLOGIC SURGERY | — | AB 265; 401; 443; 658; 682; 1303; 1612 SB 17; 221; 258; 351; 487; 790; 798 | #2175450 |
| 04/01/2017–06/30/2017 | Employer Report | CELGENE CORPORATION | Celgene | AB 265; SB 17, 212, 790 | #2171550 |
| 04/01/2017–06/30/2017 | Employer Report | CONSUMER FEDERATION OF CALIFORNIA | — | AB 87, 103, 165, 168, 175, 243, 265, 314, 375, 380, 413, 502, 550, 611, 713, 726, 814, 853, 859, 889, 940, 965, 1054, 1056, 1070, 1108, 1185, 1255, 1429, 1127, 1526, 1575, 1679; SB 16, 17, 21, 33, 62, 63, 66, 71, 87 202, 219, 244, 300, 313, 520, 562, 566, 598, 641, 648, 649, Dept. of Insurance, Gov?s office. | #2169383 |
| 04/01/2017–06/30/2017 | Employer Report | CVS HEALTH | CVS/CAREMARK CORPORATION | AB 40, 113, 265, 315, 444, 514, 1560, 1589; SB 212, 244; LEGISLATURE RE: STATE BUDGET | #2176040 |
| 04/01/2017–06/30/2017 | Employer Report | Daiichi Sankyo Inc. | DAIICHI SANKYO INC. | Legislature: AB 265; AB 1512; SB 17; SB 790. | #2171597 |
| 04/01/2017–06/30/2017 | Employer Report | ENDO | — | Legislature: AB29, AB265, AB315, AB1512, SB17, SB790 | #2173311 |
| 04/01/2017–06/30/2017 | Employer Report | EXPRESS SCRIPTS HOLDING COMPANY | — | Legislature: AB 29, AB 265, AB 315, AB 1353, AB 1512. Governor's Office: AB 315. Department of Managed Health Care: AB 315. Department of Finance: AB 315. Health and Human Services Agency: AB 315. | #2167977 |
| 04/01/2017–06/30/2017 | Employer Report | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | INSPERITY SERVICES, L.P. | AB 1, 29, 265, 315, 444, 1107, 1512; ACR 11; SB 1, 17, 212, 567, 790 | #2173998 |
| 04/01/2017–06/30/2017 | Employer Report | GLAXOSMITHKLINE | — | Legislature: AB29, AB265, AB315, AB889, SB17, SB562, SB790, Affinity update and progress in HIV/AIDS data sharing with Medi-Cal health plans | #2173314 |
| 04/01/2017–06/30/2017 | Employer Report | Greenwich Biosciences, Inc. | Greenwich Biosciences, Inc. | AB 265, 845; SB 17 | #2169247 |
| 04/01/2017–06/30/2017 | Employer Report | GRIFOLS SHARED SERVICES NORTH AMERICA, INC. | — | Legislature: AB29, AB265, AB315, AB613, SB17 | #2173318 |
| 04/01/2017–06/30/2017 | Employer Report | HEALTH NET COMPANIES & CA HEALTH AND WELLNESS, WHOLLY OWNED SUBSIDIARIES OF CENTENE, INC | HEALTH NET COMPANIES AND CALIFORNIA HEALTH AND WELLNESS | SB 17, 33, 199, 221, 538, 562; AB 29, 265, 315, 595; DEPARTMENT OF MANAGED CARE AND DEPARTMENT OF INSURANCE: VARIOIUS MATTERS; AB 1048, 1074, 1092, 1107, 1110, 113, 120, 1316, 15, 1534, 156, 157, 1601, 182, 205, 224, 251, 265, 29, 315, 391, 40, 417, 43, 447, 595, 97; SB 133, 134, 17, 171, 172, 191, 199, 221, 222, 223, 288, 294, 33, 374, 399, 456, 538, 562, 636, 647, 743, 753; AB 43 | #2171985 |
| 04/01/2017–06/30/2017 | Employer Report | HEMOPHILIA COUNCIL OF CALIFORNIA | HEMOPHILIA COUNCIL OF CALIFORNIA | STATE BUDGET: MEDI-CAL CCS GHPP CCS REDESIGN MEDI-CAL PHARMACY FUNDING ISSUE PER FEDERAL CMS RULING SB 152 AB 613 SCR 33 AB 265 | #2176629 |
| 04/01/2017–06/30/2017 | Employer Report | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | AB 265, 514, 602, 1512; SB 17, 258, 327, 567, 790; DEPARTMENT OF TOXIC SUBSTANCES CONTROL - RETAIL WASTE, TOXICITY TESTING, THE SAFER CONSUMER PRODUCTS PROGRAM AND AA GUIDANCE DOCUMENT | #2174478 |
| 04/01/2017–06/30/2017 | Employer Report | KALEO | — | Lobbied the Legislature regarding AB 265 and SB 17. | #2172547 |
| 04/01/2017–06/30/2017 | Employer Report | MALLINCKRODT, LLC | — | AB 265, AB 1512, SB 17; SB 790 | #2171605 |
| 04/01/2017–06/30/2017 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 419, 443, 567 and Opioid Abuse Policy | #2170068 |
| 04/01/2017–06/30/2017 | Employer Report | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | MERCK & CO., INC. including MERCK HUMAN HEALTH DIVISION and MERCK MEDCO MANAGED CARE AND MEDCO CAL | AB 265; SB 17, 790 | #2174064 |
| 04/01/2017–06/30/2017 | Employer Report | NATIONAL MULTIPLE SCLEROSIS SOCIETY | — | AB 205 Members, Asm. Approp. Cmte. Members, Sen. Health Cmte. AB 265 John Gilman, Liz Snow, Cnslts, Asm.Health Cmte. AB 550 Asm Reyes; Members,Asm Approp. Cmte. | #2173813 |
| 04/01/2017–06/30/2017 | Employer Report | NOVARTIS SERVICES, INC | — | Governor's Office, Department of Health Care Services, Health and Human Services Agency Business, Consumer Services and Housing, Agency Department of Finance, CA Dept of Public Health, AB 265, SB 17, SB 790 | #2168075 |
| 04/01/2017–06/30/2017 | Employer Report | NOVO NORDISK, INC. | — | State legislature: AB 265; SB 17, 790. | #2173379 |
| 04/01/2017–06/30/2017 | Employer Report | OTSUKA AMERICA PHARMACEUTICAL, INC. | — | CALIFORNIA STATE LEGISLATURE REGARDING: AB 265, AB 587, SB 8, SB 17, SB 212, SB 790 | #2168828 |
| 04/01/2017–06/30/2017 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 29, 40, 182, 186, 265, 315, 444, 587, 715, 904, 1048, 1107, 1353, 1368, 1512; ACR 14, 18; ACA 4; SB 17, 199, 212, 419, 562, 641, 790; Patient Access and Transparency | #2171820 |
| 04/01/2017–06/30/2017 | Employer Report | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | MIDPENINSULA REGIONAL OPEN SPACE DISTRICT | AB 29, 265, 315 | #2172920 |
| 04/01/2017–06/30/2017 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 29, 265, 1512; SB 17, 790; AB 715, 1386 | #2172782 |
| 04/01/2017–06/30/2017 | Employer Report | Plasma Protein Therapeutics Association | Plasma Protein Therapeutics Association | Bills lobbied: AB 265, AB 613, SB 17, SB 790. Department of Health Care Services - Outpatient Drug Reimbursement Rule - Blood Factors. | #2177193 |
| 04/01/2017–06/30/2017 | Employer Report | ROCHE DIAGNOSTICS CORPORATION | ROCHE DIAGNOSTICS | Legislature: AB 265; AB 444; AB 602; SB 43; SB 212; SB 327. | #2171616 |
| 04/01/2017–06/30/2017 | Employer Report | Sanofi US | Sanofi US Services Inc. and sanofi pasteur | Legislature: AB 265; SB 17; SB 790. | #2172359 |
| 04/01/2017–06/30/2017 | Employer Report | SUNOVION PHARMACEUTICALS INC. | SUNOVION PHARMACEUTICALS INC. | Legislature: AB 29; AB 265; AB 315; AB 444; AB 532; SB 17; SB 562; SB 790. | #2172333 |
| 04/01/2017–06/30/2017 | Employer Report | TAKEDA PHARMACEUTICALS AMERICA | — | Legislature: AB 29, AB265, AB315, SB17, SB562, SB 790 | #2176603 |
| 04/01/2017–06/30/2017 | Employer Report | UCB INC. | UCB INC. | Legislature: AB 29; AB 265; AB 315; AB 414; SB 17; SB 562; SB 790. | #2172328 |
| 04/01/2017–06/30/2017 | Employer Report | UNITED HEALTHCARE SERVICES, INC. | — | AB 29, AB 156, AB 182, AB 265, AB 315, AB 401, AB 532, AB 587, AB 715, AB 904, AB 1353, AB 1512, SB 17, SB 43, SB 133, SB 134, SB 199, SB 221, SB 315, SB 419, SB 437, SB 443, SB 476, SB 510, SB 528, SB 562, SB 608, SB 641, Department of HealthCare Services regarding MediCal program, and CalPers. | #2169148 |
| 04/01/2017–06/30/2017 | Employer Report | VERTEX PHARMACEUTICALS INCORPORATED | — | AB 265, SB 17, SB 790, SR 34, Cystic Fibrosis Research Inc. Lobby Day, Rare Diseases. | #2171573 |
| 04/01/2017–06/30/2017 | Employer Report | WESTERN CENTER ON LAW & POVERTY, INC. | — | AB:5,9,10,17,21,34,42,43,60,62,71,72,74,75,85,90,97,103,120,160,164,167,180,181,204,205,210,214,225,227,236,265,266,273,285,291,298,323,340,342,344,345,391,412,415,435,447,450,453,470,480,503,557,563,569,571,572,595+ SB:2,3,6,10,16,17,31,34,41,54,87,97,138,152,164,166,171,180,185,190,191,21,219,222,223,232,239,241,244,250,277,278,282,298,310,316,354,360,377,380,396,439,469,491,557,562,570,575+ | #2176840 |
| 01/01/2017–03/31/2017 | Employer Report | 880 PHARMACY INC. | 880 PHARMACY INC. | AB 265, 315, 612 | #2156809 |
| 01/01/2017–03/31/2017 | Employer Report | ABBVIE | ABBVIE | AB 265, 587, 1107, 1512; SB 17, 567, 790 | #2154148 |
| 01/01/2017–03/31/2017 | Employer Report | American Cancer Society Cancer Action Network Inc. | American Cancer Society Cancer Action Network Inc. | AB 62, 179, 182, 265, 715: ACR 11, 36; SB 55, 172, 223, 294, 300, 386, 419, 440. | #2158166 |
| 01/01/2017–03/31/2017 | Employer Report | American Federation of State, County and Municipal Employees California People | American Federation of State, County and Municipal Employees California People | AB 156, 157, 180, 205, 207, 265, 391, 595, 1240, 1258, 1353; SB 17, 133, 134, 152, 171, 199, 202, 220, 223, 349, 487, 562, 575, 762; Governor, Covered California: health reform. | #2157935 |
| 01/01/2017–03/31/2017 | Employer Report | AMERICAN LUNG ASSOCIATION IN CALIFORNIA | AMERICAN LUNG ASSOCIATION IN CALIFORNIA | CARB CEC BOE Governor's Office AB 32/SB 32 Implementation Proposition 56 Implementation SB 1 SB 41 SB 49 SB 254 SB 386 SB 440 SB 563 SB 719 AB 62 AB 262 AB 265 AB 378 AB 391 AB 511 AB 582 AB 725 AB 1205 | #2155434 |
| 01/01/2017–03/31/2017 | Employer Report | AMERICAN NURSES ASSOCIATION/CALIFORNIA | CALIFORNIA NURSE MIDWIVES ASSOCIATION (CNMA) | AB 9, 10, 40, 44, 156, 164, 182, 186, 191, 223, 229, 254, 265, 286, 305, 387, 401, 422, 569, 836, 859, 882, 893, 1258, 1382, 1560, 1612; HR 6; SB 17, 18, 23, 27, 43, 133, 134, 176, 245, 250, 294, 309, 320, 349, 554, 562, 743, 799; SR 26 | #2152500 |
| 01/01/2017–03/31/2017 | Employer Report | AMERICA'S HEALTH INSURANCE PLANS (AHIP) | AMERICA'S HEALTH INSURANCE PLANS | AB 29, 172, 265, 315, 595, 1107, 1316, 1353, 1534, 1601; SB 17, 221, 223, 399; LEGISLATURE RE: COORDINATED CARE INITIATIVE; DEPT OF FINANCE RE: COORDINATED CARE INITIATIVE; 403(B) TBL, HIGH COST DRUGS | #2156411 |
| 01/01/2017–03/31/2017 | Employer Report | AMGEN | AMGEN | Legislature: AB 265; AB 315; AB 444; AB 587; SB 17; SB 567; SB 790. | #2154242 |
| 01/01/2017–03/31/2017 | Employer Report | ASTELLAS PHARMA US, INC. | — | Legislature regarding AB 29, AB 315, AB 265, AB 587, AB 107, AB 1512, SB 17, SB 462, SB 790. | #2153208 |
| 01/01/2017–03/31/2017 | Employer Report | ASTRA ZENECA PHARMACEUTICALS, LP | — | Legislature: AB265, AB1107, SB17 | #2157229 |
| 01/01/2017–03/31/2017 | Employer Report | BAYER U.S. LLC | — | AB 9, AB 265, SB 17, SB 602 | #2153527 |
| 01/01/2017–03/31/2017 | Employer Report | BIOCOM | — | Legislature: AB 182, AB 265, AB 602, AB 1512, SB 790. AB 444, SB 17, SB 212, Opening of Biocom office in LA, BIO Convention in San Diego Administration: BIO convention in San Diego | #2156910 |
| 01/01/2017–03/31/2017 | Employer Report | BIOGEN | BIOGEN IDEC | Legislature: SB 17; SB 23; SB 440; SB 419; AB 265; AB 315; AB 1512; AB 624; AB 602; AB 207; AB 182; AB 845; AB 613. | #2155439 |
| 01/01/2017–03/31/2017 | Employer Report | BIOTECHNOLOGY INNOVATION ORGANIZATION | BIO (BIOTECHNOLOGY INDUSTRY ORGANIZATION) | Legislature: AB 265; AB 444; AB 587; SB 17; SB 212. | #2153626 |
| 01/01/2017–03/31/2017 | Employer Report | BLUE SHIELD OF CALIFORNIA | BLUE SHIELD OF CALIFORNIA | AB 29, 205, 224, 265, 315, 340, 391, 447, 595, 814, 904, 1074, 1092, 1107, 1110, 1316, 1353, 1534, 1601, 1643; SB 17, 33, 171, 172, 191, 199, 221, 223, 294, 374, 399, 538, 562, 636, 790; DEPT OF HEALTH CARE SERVICES, DEPT OF MANAGED HEALTH CARE, HEALTH & HUMAN SERVICES AGENCY RE: SPECIALTY DRUGS, DUAL ELIGIBLE PROGRAM, 3RD PARTY PAYMENTS, LEGISLATION; HEALTH BENEFIT EXCHANGE RE: 2017 PLANS | #2156729 |
| 01/01/2017–03/31/2017 | Employer Report | BOEHRINGER INGELHEIM | — | AB 265; SB 17, 66, 567, 790 | #2152203 |
| 01/01/2017–03/31/2017 | Employer Report | CALIFORNIA ACCESS COALITION | CALIFORNIA ACCESS COALITION | AB74AB182AB186AB208AB210Ab232AB244AB265AB296AB340AB395AB456AB470AB620AB665AB675AB683AB715AB727AB824AB850AB860AB1095AB1134AB1136AB1188AB1340Ab1353AB1362AB1368SB8Sb34Sb142Sb143SB191SB215Sb218Sb222Sb237SB323SB374Sb409SB456SB636SB688SB786 | #2152980 |
| 01/01/2017–03/31/2017 | Employer Report | CALIFORNIA CHRONIC CARE COALITION | — | Legislature: AB265, AB1353, SB17, AB641 | #2157260 |
| 01/01/2017–03/31/2017 | Employer Report | CALIFORNIA RHEUMATOLOGY ALLIANCE | — | AB 1353, AB 265, AB 315, SB 300 | #2153804 |
| 01/01/2017–03/31/2017 | Employer Report | CAPG | California Association of Physician Groups | AB 595, 156, 157, 180, 265, 315, 387, 1643; SB 172, 349, 538, 562, 17, 133, 134, 199, 790. CA Dept of Managed Health Care re: AB 72 and SB 137. CA Dept of Health Care Services re: Medicaid managed care final rule. | #2156827 |
| 01/01/2017–03/31/2017 | Employer Report | CELGENE CORPORATION | Celgene | AB 29, 265, 1107, 1353; SB 17, 212 | #2152502 |
| 01/01/2017–03/31/2017 | Employer Report | CONSUMER FEDERATION OF CALIFORNIA | — | Legislature: AB 87, 165, 168, 175, 265, 314, 375, 380, 413, 502, 550, 611, 713, 726, 814, 853, 859, 889, 940, 965, 1054, 1056, 1070, 1108, 1185, 1255, 1429, 1127, 1526, 1575, 1679; SB 16, 17, 21, 33, 62, 63, 66, 71, 202, 219, 244, 300, 313, 520, 562, 566, 598, 641, 648, 649, Dept. of Insurance, Gov?s office | #2156158 |
| 01/01/2017–03/31/2017 | Employer Report | CYSTIC FIBROSIS FOUNDATION | CYSTIC FIBROSIS FOUNDATION | AB 265; SB 152; BUDGET ACT - LEGISLATURE | #2157037 |
| 01/01/2017–03/31/2017 | Employer Report | Daiichi Sankyo Inc. | DAIICHI SANKYO INC. | Legislature: AB 265 and AB 1512. | #2153053 |
| 01/01/2017–03/31/2017 | Employer Report | ENDO | — | Legislature: AB29, AB265, AB315, AB1512, SB17 | #2157264 |
| 01/01/2017–03/31/2017 | Employer Report | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | INSPERITY SERVICES, L.P. | AB 1, 29, 265, 315, 401, 444, 1107, 1512; ACR 11; SB 1, 17, 212, 567, 790 | #2157873 |
| 01/01/2017–03/31/2017 | Employer Report | GLAXOSMITHKLINE | — | Legislature: AB29, AB265, AB315, AB889, SB17, Affinity update and progress in HIV/AIDS data sharing with Medi-Cal health plans | #2157271 |
| 01/01/2017–03/31/2017 | Employer Report | GRIFOLS SHARED SERVICES NORTH AMERICA, INC. | — | Legislature: AB29, AB265, AB315, AB613, SB17 | #2157719 |
| 01/01/2017–03/31/2017 | Employer Report | HEMOPHILIA COUNCIL OF CALIFORNIA | HEMOPHILIA COUNCIL OF CALIFORNIA | STATE BUDGET: MEDI-CAL CCS AND GHPP. CCS REDESIGN MEDI-CAL PHARMACY ISSUE PER FED CMS RULING SB 152 AB 613 SCR 33 AB 265. | #2157634 |
| 01/01/2017–03/31/2017 | Employer Report | KALEO | — | Lobbied the Legislature regarding AB 265, SB 17 and non-legislation-specific issues of interest. | #2152591 |
| 01/01/2017–03/31/2017 | Employer Report | LEAGUE OF CALIFORNIA CITIES | — | AB: 1, 6, 9, 18, 20, 27, 28, 30, 44, 45, 48, 52, 53, 59, 64, 71, 72, 74, 76, 79, 175, 178, 181, 190, 198, 239, 241, 252, 265, 299, 332, 346, 352, 390, 420, 428, 459, 485, 525, 530, 561, 565, 636, 663, 672, 678, 686, 694, 729, 735, 748, 765, 804, 852, 879, 886, 887, 890, 920, 943, 960, 982, 1002, 1066, 1103, 1008, 1017, 1117, 1120, 1127, 1145, 1147, | #2155760 |
| 01/01/2017–03/31/2017 | Employer Report | MALLINCKRODT, LLC | — | AB 265, AB 1512, SB 17 | #2152263 |
| 01/01/2017–03/31/2017 | Employer Report | MC KESSON CORPORATION | — | Legislature re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 176, 212, 419, 443 | #2156117 |
| 01/01/2017–03/31/2017 | Employer Report | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | MERCK & CO., INC. including MERCK HUMAN HEALTH DIVISION and MERCK MEDCO MANAGED CARE AND MEDCO CAL | AB 265, 315; SB 17 | #2156775 |
| 01/01/2017–03/31/2017 | Employer Report | NOVARTIS SERVICES, INC | — | Governor's Office, Department of Health Care Services, Health and Human Services Agency Business, Consumer Services and Housing, Agency Department of Finance, AB 444,265,587; SB 17,212,562,567 | #2151729 |
| 01/01/2017–03/31/2017 | Employer Report | NOVO NORDISK, INC. | — | State legislature: AB 265, 315; SB 17. | #2152751 |
| 01/01/2017–03/31/2017 | Employer Report | OTSUKA AMERICA PHARMACEUTICAL, INC. | — | CALIFORNIA STATE LEGISLATURE REGARDING: AB 265, AB 587, SB 8, SB 17, SB 212 | #2151492 |
| 01/01/2017–03/31/2017 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB: 29, 40, 182, 186, 265, 315, 444, 587, 715, 904, 1048, 1107, 1353, 1368, 1512; ACA: 4; ACR: 14, 18; SB: 17, 199, 212, 419, 562, 567, 641, 790; Cancer Treatment Engagement | #2154559 |
| 01/01/2017–03/31/2017 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 265; SB 17; AB 315, AB 1512; SB 17; AB 444 | #2156933 |
| 01/01/2017–03/31/2017 | Employer Report | Plasma Protein Therapeutics Association | Plasma Protein Therapeutics Association | Bills lobbied: AB 29, AB 265, AB 315, AB 587, AB 613, AB 1488, SB 17, SB 790. Department of Health Care Services - Outpatient Drug Reimbursement Rule - Blood Factors. | #2157936 |
| 01/01/2017–03/31/2017 | Employer Report | Sanofi US | Sanofi US Services Inc. and sanofi pasteur | Legislature: AB 265; AB 444; AB 1532; SB 17; SB 212; SB 790. Department of Health: Newborn screening panel. | #2155154 |
| 01/01/2017–03/31/2017 | Employer Report | SUNOVION PHARMACEUTICALS INC. | SUNOVION PHARMACEUTICALS INC. | Legislature: AB 29; AB 265; AB 315. | #2153039 |
| 01/01/2017–03/31/2017 | Employer Report | TAKEDA PHARMACEUTICALS AMERICA | — | Legislature: AB 29, AB265, AB315, SB17 | #2158188 |
| 01/01/2017–03/31/2017 | Employer Report | UCB INC. | UCB INC. | Legislature: AB 29; AB 265; AB 315; AB 444; AB 587; AB 1353; SB 17; SB 212; SB 562; SB 567; SB 790. | #2154238 |
| Period | Form | Employer | Firm / Filer | Fees | Reimb. | Period Total | Cumulative | Lobbying Activity | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 04/01/2018–06/30/2018 | Firm Activity (payments) | AstraZeneca Pharmaceuticals LP | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $0 | $0 | $0 | $130,000 | Legislature: SB790; asthma and oncology issues; diabetes and cardiovascular health issues; Budget re CDPH long-range asthma plan; AB265 Implementation; - Continued in Memo. | #2276754 |
| 01/01/2018–03/31/2018 | Firm Activity (payments) | AstraZeneca Pharmaceuticals LP | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $65,000 | $0 | $65,000 | $130,000 | Legislature: SB790, diabetes and cardiovascular health issues; Budget re CDPH long-range asthma plan; AB265 implementation asthma issues; OSHPD: SB17 implementation. | #2242516 |
| 01/01/2018–03/31/2018 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $126,190 | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512, 1751, 1752, 1753, 1963, 1998, 2174, 2256, 2384, 2486, 2487, 2741, 2760, | #2236701 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | BLUE SHIELD OF CALIFORNIA | WEIDEMAN GROUP, INC. | $20,000 | $0 | $20,000 | $260,000 | AB 265, AB 315, SB 17, SB 133, SB 538, SB 562 | #2209477 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | California Academy of Family Physicians | Dimare, Brown, Hicks & Kessler, LLC | $30,000 | $200 | $30,200 | $120,980 | AB 40,247,265,340,443,447,461,841,1002,1048,1316,1340; SB 17,54,223,294,396,437,536,554,796,798; SR 37 -- Governor; Payments Partially for 3rd Quarter, 2017. | #2206864 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | California Podiatric Medical Association | Dimare, Brown, Hicks & Kessler, LLC | $13,500 | $0 | $13,500 | $54,820 | AB 265, AB 715, AB 1153, SB 17, SB 241, SB 554, SB 798 -- Governor; Payments Partically for 3rd Quarter, 2017. | #2206864 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | California Professional Firefighters | CAPITOL CONNECTION | $109,878 | $0 | $109,878 | $426,114 | Governor's Office re: AB 20, AB 44, AB 46, AB 55, AB 61, AB 199, AB 249, AB 265, AB 450, AB 512, AB 530, AB 568, AB 570, AB 722, AB 725, AB 848, AB 890, AB 901, AB 978, AB 1120, AB 1157, AB 1194 | #2205146 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | CELGENE CORPORATION | HAWKINS STRATEGIC ADVOCACY | $18,000 | $0 | $18,000 | $78,000 | AB 265; SB 17, 212, 790 | #2209508 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | Consumer Federation of California | HERNANDEZ STRATEGY GROUP | $13,590 | $0 | $13,590 | $54,360 | Legislature: AB 87, 103, 165, 168, 175, 243, 265, 314, 375, 380, 413, 502, 550, 611, 713, 726 ,814, 853, 859, 889,940, 965, 1054, 1056, 1070, 1108, 1185, 1255, 1429, 1127, 1526, 1575 ,1679; | #2207562 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | HEMOPHILIA COUNCIL OF CALIFORNIA | COWGER & ASSOCIATES | $13,200 | $0 | $13,200 | $52,800 | STATE BUDGET: MEDI-CAL CCS GHPP. CCS REDESIGN & WHOLE CHILD MODEL. PHARMACY ISSUE PER FEDERAL CMS RULING.SB 152 AB 613 SCR 33 AB 265AB 1250. | #2210682 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | kaleo | CAPITOL ADVOCACY, LLC | $22,500 | $0 | $22,500 | $90,000 | Lobbied the Legislature regarding AB 265, opioid overdose and prevention. | #2211524 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $102,565 | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 443 and Opioid Abuse Policy and ePrescribing legislation | #2208940 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | NOVARTIS SERVICES, INC. | GOVERNMENTAL ADVOCATES, INC. | $30,000 | $650 | $30,650 | $120,650 | AB 265; SB 17 | #2207957 |
| 07/01/2017–09/30/2017 | Employer Payments to Firms | Ackler & Associates | DAIICHI SANKYO | $17,400 | $0 | $17,400 | $52,200 | Legislature: AB 265; SB 17; SB 790. | #2191166 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | AIDS Healthcare Foundation | MVM STRATEGY GROUP | $37,500 | $496 | $37,996 | $113,255 | Governor re: general HIV health issues. Governor and Legislature re: AB 265, SB 2, SB 17 and SB 35. Legislature re: AB 249, AB 511, AB 587, AB 1033, AB 1250, AB 1534 and SB 790. | #2190066 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Alkermes | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $12,000 | $12 | $12,012 | $12,012 | Legislature: AB182, AB532, AB265, SB17, SB790 | #2194116 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | ALLERGAN USA | PLATINUM ADVISORS, LLC | $33,000 | $0 | $33,000 | $88,000 | AB 265, 443; SB 17, 510, 790 | #2191330 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | American College of Pyhsicians - CA Chapter | CAL CAPITOL GROUP | $6,500 | $0 | $6,500 | $19,500 | AB 148; 265; 1221; 1316; 1534 SB 17; 323; 396; 790; 798 | #2194095 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES CALIFORNIA PEOPLE | CAPELL & ASSOCIATES | $6,000 | $0 | $6,000 | $16,000 | AB 156, 157, 180, 205, 207, 265, 391, 595, 1240, 1258, 1353; SB 17, 133, 134, 152, 171, 199, 202, 220, 223, 349, 487, 562, 575, 762; LEGISLATURE, GOVERNOR'S OFFICE, COVERED CA RE: HEALTH REFORM | #2190533 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | American G.I Forum of California | CONATY & ASSOCIATES; PETE | $0 | $0 | $0 | $0 | AB85, AB153, AB172, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1403, AB1618, AB1710, AB1711, | #2189192 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | American Legion, Department of California | CONATY & ASSOCIATES; PETE | $4,500 | $1,615 | $6,115 | $17,856 | AB85, AB153, AB172, AB226, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, AB1710, | #2189192 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | AMVETS, Department of California | CONATY & ASSOCIATES; PETE | $2,800 | $450 | $3,250 | $16,631 | AB85, AB153, AB172, AB226, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, AB1710, | #2189192 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Astellas Pharma US, Inc. | MANATT, PHELPS & PHILLIPS, LLP | $27,000 | $0 | $27,000 | $90,041 | AB 265, AB 315, SB 17, SB 790, | #2193170 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | AstraZeneca Pharmaceuticals LP | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $0 | $0 | $0 | $65,000 | Legislature: AB265, SB17, SB790, diabetes and cardiovascular health issues | #2194116 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | BAYER U.S., INC. | NOTEWARE GOVERNMENT RELATIONS | $7,500 | $0 | $11,035 | $40,873 | AB 265; SB 17, SB 790 | #2188969 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | BIOCOM | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $27,500 | $0 | $27,500 | $81,000 | AB 182, 265, 444, 602; SB 17, 212, 790; SCA 7 | #2194001 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Biotechnology Innovation Organization | CAPITOL ADVOCACY, LLC | $36,000 | $88 | $36,088 | $108,358 | Lobbied the Legislature regarding SB 17, SB 790 and AB 265. | #2191171 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | BLUE SHIELD OF CALIFORNIA | WEIDEMAN GROUP, INC. | $60,000 | $0 | $60,000 | $240,000 | AB 265, AB 315, SB 17, SB 133, SB 538, SB 562 | #2192678 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Boehringer Ingelheim Pharmaceuticals, Inc. | NORWOOD ASSOCIATES LLC | $24,000 | $888 | $24,888 | $65,725 | Checks from Boehringer Ingelheim USA Corporation. AB 265, 315, 447; SB 17, 790. | #2189387 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | BRISTOL-MYERS SQUIBB COMPANY | POLITICAL SOLUTIONS, LLC | $41,160 | $0 | $41,160 | $113,634 | AB 265; SB 17, 790 | #2192796 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Academy of Family Physicians | Dimare, Brown, Hicks & Kessler, LLC | $30,000 | $0 | $30,000 | $90,780 | AB 40,97,148,265,315,340,443,461,508,715,841,1002,1048,1316,1340,1368,1560; SB 17,54,97,223,294,374,396,437,536,554,790,796,798; SR 37 -- Legislature; Payments Partially for 2nd Quarter, 2017. | #2191517 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | CALIFORNIA ASSOCIATION OF COUNTY VETERANS SERVICE OFFICERS | CONATY & ASSOCIATES; PETE | $6,000 | $0 | $6,000 | $20,830 | AB85, AB153, AB172, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, AB1618, AB1710, | #2189192 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Chronic Care Coalition | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $9,000 | $22 | $9,022 | $24,032 | Legislature: AB613, AB182 AB265, AB1250, SB17, SB374, SB133, SB349, SB790 | #2194116 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Life Sciences Association | Gonzalez Government Consulting | $18,000 | — | $18,000 | $60,000 | Bills lobbied: AB 29, AB 97, AB 182, AB 186, AB 207, AB 315, AB 265, AB 447, AB 479, AB 602, AB 613, AB 845, AB 889, AB 1512, ACA 4, SB 17, SB 97, SB 327, SB 419, SB 567, SB 790. | #2194393 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | CALIFORNIA LIFE SCIENCES ASSOCIATION (CLSA) | CARPENTER SIEVERS LLC | $34,500 | $179 | $34,679 | $106,102 | AB 182, 186, 265, 315, 444, 447, 602, 613, 845, 1217, 1386; ACR 93, 94; SB 17, 212, 440, 790; SCR 27; SR 37 | #2189428 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Podiatric Medical Association | Dimare, Brown, Hicks & Kessler, LLC | $13,500 | $613 | $14,113 | $41,320 | AB 97, AB 186, AB 265, AB 508, AB 715, AB 1153, SB 17, SB 97, SB 241, SB 554, SB 798 -- Legislature; Payments Partically for 2nd Quarter, 2017. | #2191517 |
| 04/01/2017–09/30/2017 | Firm Activity (payments) | California Professional Firefighters | CAPITOL CONNECTION | $112,557 | $0 | $112,557 | $206,358 | AB 54, AB 61, AB 71, AB 77, AB 78, AB 89, AB 151, AB 198, AB 199, AB 206, AB 211, AB 216, AB 221, AB 225, AB 252, AB 263, AB 265, AB 281, AB 283, AB 292, AB 315, AB 316, AB 362, AB 387, AB 425 | #2177484 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Professional Firefighters | CAPITOL CONNECTION | $109,878 | $0 | $109,878 | $316,236 | AB 14, AB 20, AB 44, AB 55, AB 61, AB 109, AB 134, AB 199, AB 216, AB 249, AB 265, AB 301 | #2192897 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | CALIFORNIA PSYCHIATRIC ASSOCIATION | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $19,500 | $0 | $19,500 | $58,500 | AB 186, 265, 720, 1136; SB 374, 790, 798 | #2193768 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Public Interest Research Group, Inc. | RUSCH; EMILY | $4,464 | $551 | $5,015 | $11,543 | AB 587; AB 265; AB 315; SB 100; AB 1407; AB 1678; SB 17; AB 918; SB 727; SB 33; AB 249; SB 258; AB 375; SB 313; SB 1316; AB 1328; SB 790 | #2192335 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Rheumatology Alliance | KL GOVERNMENT AFFAIRS | $13,980 | $0 | $13,980 | $39,780 | AB 1353, AB 265, AB 315, SB 300 | #2190631 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California State Commanders Veterans Council | CONATY & ASSOCIATES; PETE | $0 | $0 | $0 | $1,700 | AB85, AB153, AB172, AB226, AB242, AB265, AB266, AB296, AB331, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB522, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, | #2189192 |
| 07/01/2017–09/30/2017 | Employer Payments to Firms | Capitol Advocacy LLC | BIOTECHNOLOGY INNOVATION ORGANIZATION | $36,000 | $88 | $36,088 | $108,358 | Legislature: AB 265; SB 17; SB 790. | #2192296 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | CAPITOL ADVOCACY, LLC ON BEHALF OF UNITED HEALTHCARE | WEST COAST ADVISORS | $10,000 | $0 | $10,000 | $35,000 | AB 29, 156, 157, 182, 265, 315, 401, 532, 587, 715, 904, 1353, 1512; SB 17, 43, 133, 134, 221, 315, 419, 437, 443, 476, 510, 528, 608, 641 | #2192674 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | CELGENE CORPORATION | HAWKINS STRATEGIC ADVOCACY | $18,000 | $0 | $18,000 | $60,000 | AB 265; SB 17, 212, 790 | #2193548 |
| 07/01/2017–09/30/2017 | Employer Payments to Firms | Clear Advocacy LLC | Sanofi US | $13,750 | $306 | $14,056 | $41,557 | Legislature: AB 265; AB 315; AB 602; SB 17; SB 790. | #2192175 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | CLEAR ADVOCACY, LLC (ON BEHALF OF SANOFI US SERVICES, INC) | JK PEDROTTI, INC. GOV'T RELATIONS | $13,750 | $306 | $14,056 | $41,557 | AB 265, 315, 602; SB 17, 790 | #2192734 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Consumer Federation of California | HERNANDEZ STRATEGY GROUP | $13,590 | $0 | $13,590 | $40,770 | Legislature: AB 87, 103, 165, 168, 175, 243, 265, 314, 375, 380, 413, 502, 550, 611, 713, 726 ,814, 853, 859, 889,940, 965, 1054, 1056, 1070, 1108, 1185, 1255, 1429, 1127, 1526, 1575 ,1679; | #2191300 |
| 07/01/2017–09/30/2017 | Employer Payments to Firms | COWGER & ASSOCIATES | HEMOPHILIA COUNCIL OF CALIFORNIA | $0 | $0 | $0 | $39,600 | STATE BUDGET: MEDI-CAL CCS GHPP CCS REDESIGN MEDI-CAL PHARMACY FUNDING ISSUE PER FEDERAL CMS RULING SB 152 AB 613 SCR 33 AB 265 AB 1250 | #2193943 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Daiichi Sankyo | ACKLER & ASSOCIATES | $17,400 | $0 | $17,400 | $52,200 | AB 265 SB 17 SB 790 | #2191184 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Endo | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $5,000 | $0 | $5,000 | $28,000 | Legislature: AB715, AB265, AB315, SB17, SB790 | #2194116 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $27,000 | $313 | $27,313 | $90,895 | AB 265; SB 17, 790 | #2193768 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | GILEAD SCIENCES, INC. | NOTEWARE GOVERNMENT RELATIONS | $30,000 | $0 | $30,000 | $102,128 | AB 265; SB 790 | #2188969 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | GlaxoSmithKline | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $22,500 | $0 | $22,500 | $75,000 | Legislature: AB265, AB315, AB444, SB212, SB17, SB790, SCR74, Affinity project update & progress HIV/AIDS data sharing with Medi-Cal | #2194116 |
| 07/01/2017–09/30/2017 | Employer Payments to Firms | Gonzalez Government Consulting | Plasma Protein Therapeutics Association | $8,000 | $0 | $8,000 | $25,000 | Bills lobbied: AB 265, AB 613, SB 17, SB 790. Department of Health Care Services - Outpatient Drug Reimbursement Rule - Blood Factors. | #2194404 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | GREENWICH BIOSCIENCES, INC. | GOVERNMENTAL ADVOCATES, INC. | $22,500 | $0 | $22,500 | $67,500 | AB 845,265,SB 17 | #2191399 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Grifols Shared Services North America, Inc. | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $10,000 | $84 | $10,084 | $45,556 | Legislature: AB265, AB315, AB613, SB17SB790; CDPH: Plasma Center Personnel | #2194116 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | HEMOPHILIA COUNCIL OF CALIFORNIA | COWGER & ASSOCIATES | $0 | $0 | $0 | $39,600 | STATE BUDGET: MEDI-CAL CCS GHPP CCS REDESING PHARMACY ISSUE PER FEDERAL CMS RULING SB 152 AB 613 SCR 33 AB 265 AB 1250 | #2193977 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $15,663 | $503 | $16,166 | $34,135 | AB 265; SB 17, 790 | #2193768 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | kaleo | CAPITOL ADVOCACY, LLC | $22,500 | $0 | $22,500 | $67,500 | Lobbied the Legislature regarding AB 265 and SB 17. | #2191171 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | MALLINCKRODT, LLC | NOTEWARE GOVERNMENT RELATIONS | $12,000 | $0 | $12,000 | $54,000 | AB 265; SB 17, SB 790 | #2188969 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $78,940 | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 443 and Opioid Abuse Policy | #2193778 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $29,242 | $0 | $29,242 | $55,565 | AB 265; SB 17, 790 | #2193768 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Military Officers Association of America, California Council of Chapters | CONATY & ASSOCIATES; PETE | $500 | $0 | $500 | $2,000 | AB85, AB153, AB172, AB242, AB265, AB266, AB296, AB353, AB360, AB363, AB365, AB376, AB386, AB431, AB547, AB665, AB671, AB737, AB866, AB1106, AB1165, AB1249, AB1269, AB1365, AB1403, AB1618, AB1710, | #2189192 |
| 07/01/2017–09/30/2017 | Employer Payments to Firms | Noteware Government Relations | UCB INC. | $15,000 | $0 | $15,000 | $25,000 | Legislature: AB 265; SB 17; SB 790. | #2191521 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | NOVARTIS SERVICES, INC. | GOVERNMENTAL ADVOCATES, INC. | $30,000 | $0 | $30,000 | $90,000 | AB 265,SB 17,790; Dept of Managed Health Care RE: insurance coverage | #2191399 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | NOVO NORDISK, INC. | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $16,500 | $90 | $16,590 | $49,756 | AB 265; SB 17, 790 | #2193768 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. | KAHN CONSULTING; CHRIS | $12,000 | $0 | $12,000 | $36,000 | CALIFORNIA STATE LEGISLATURE REGARDING: AB 265, AB 315, AB 587, SB 8, SB 17, SB 212, SB 790. | #2193062 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | PFIZER, INC. | KAHN CONSULTING; CHRIS | $48,000 | $1,220 | $49,220 | $145,220 | CALIFORNIA STATE LEGISLATURE REGARDING: SB 17, SB 212, SB 419, SB 790, AB 265, AB 587, AB 715, AB 1353, AB 1512. | #2193062 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PUBLIC POLICY ADVOCATES, LLC | $27,500 | $540 | $28,041 | $83,871 | AB 315, AB 265 | #2187919 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $39,250 | $0 | $39,250 | $118,261 | LEGISLATURE // AB265 AB315 AB1512 SB17 SB790 | #2189164 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Plasma Protein Therapeutics Association | Gonzalez Government Consulting | $8,000 | $0 | $8,000 | $25,000 | Agencies/Bills lobbied: AB 265, AB 613, SB 17, SB 790. Department of Health Care Services: Outpatient Drug Reimbursement Rule - Blood Factors. | #2194393 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | PLATINUM ADVISORS, LLC obo ALLERGAN | TOPP STRATEGIES | $9,000 | $0 | $9,000 | $21,000 | AB 265; SB 17, 790 | #2194060 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | SANOFI US SERVICES INC. | CLEAR ADVOCACY, LLC | $13,750 | $306 | $14,056 | $41,557 | AB 265, 315, 602; SB 17, 790 | #2192717 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Sunovion Pharmaceuticals, Inc. | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $10,000 | $47 | $10,047 | $45,544 | Legislature: AB265, AB315, AB444, AB532, SB17, SB790 | #2194116 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Takeda Pharmaceuticals America | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $10,000 | $405 | $10,405 | $33,614 | Legislature: AB265, AB315, SB17, SB562, SB790 | #2194116 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | UCB, INC. | NOTEWARE GOVERNMENT RELATIONS | $15,000 | $0 | $15,000 | $25,000 | AB 265; SB 17, SB 790 | #2188969 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | VERTEX PHARMACEUTICALS INCORPORATED | TOPP STRATEGIES | $30,000 | $0 | $30,000 | $54,000 | AB 265; SB 17, 790 | #2194060 |
| 07/01/2017–09/30/2017 | Employer Payments to Firms | Wilke Fleury Hoffelt Gould & Birney LLP | SUNOVION PHARMACEUTICALS INC. | $10,000 | $47 | $10,047 | $45,544 | Legislature: AB 265; AB 315; AB 444; AB 532; SB 17; SB 790 | #2193121 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Ackler & Associates | DAIICHI SANKYO INC. | $17,400 | $0 | $17,400 | $34,800 | Legislature: AB 265; AB 1512; SB 17; SB 790. | #2171597 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | ALLERGAN USA | PLATINUM ADVISORS, LLC | $22,000 | $0 | $22,000 | $55,000 | AB 102, 265; SB 17, 510, 790 | #2176247 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | American College of Pyhsicians - CA Chapter | CAL CAPITOL GROUP | $6,500 | $0 | $6,500 | $13,000 | AB 148; 265; 859; 1221; 1316; 1534 SB 17; 43; 176; 323; 396; 419; 481; 641; 790; 798 | #2175684 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES CALIFORNIA PEOPLE | CAPELL & ASSOCIATES | $4,000 | $0 | $4,000 | $10,000 | AB 156, 157, 180, 205, 207, 265, 391, 595, 1240, 1258, 1353; SB 17, 133, 134, 152, 171, 199, 202, 220, 223, 349, 487, 562, 575, 762; LEGISLATURE, GOVERNOR'S OFFICE, COVERED CA RE: HEALTH REFORM | #2175215 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | AMERICA'S HEALTH INSURANCE PLANS (AHIP) | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $22,500 | $0 | $22,500 | $45,000 | AB 29, 265, 315, 1107, 1316, 1353, 1534; SB 17, 172, 221, 223, 399, 538, 562 | #2174845 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Amerisource Bergen Corporation | CALIFORNIA STRATEGIES & ADVOCACY, LLC | $21,000 | $0 | $21,000 | $49,000 | Board of Pharmacy re: Pharmacutical Product Stewardship Programs Compounding. Legislature re: Phamaceutical Pricing, AB 40, 43, 182, 265, 315, 444, 447, 587, 1048, 1512, SB 17, 176, 315, 510, 641 | #2176210 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | AMGEN | Matt Back Government Relations | $28,500 | $0 | $28,500 | $47,500 | Lobbied the Legislature regarding AB 265, AB 444, SB 17, SB 349 and SB 790. | #2172040 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Astellas Pharma US, Inc. | MANATT, PHELPS & PHILLIPS, LLP | $27,000 | $0 | $27,000 | $63,041 | SB 17, SB 790, AB 265, AB 315 | #2173615 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | AstraZeneca Pharmaceuticals LP | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $0 | $0 | $0 | $65,000 | Legislature: AB265, AB1107, SB17, SB790 | #2176382 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | BAYER U.S., INC. | NOTEWARE GOVERNMENT RELATIONS | $22,500 | $0 | $26,303 | $29,838 | AB 9, AB 265, AB 514; SB 17, SB 602, SB 790 | #2169554 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | BIOCOM | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $28,000 | $0 | $28,000 | $53,500 | AB 182, 265, 444, 600, 602, 1512; SB 17, 212, 327, 562, 567, 600, 790; SCA 7; LEGISLATURE RE: DRUGS & SHARPS WASTE DISPOSAL | #2174845 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Biotechnology Innovation Organization | CAPITOL ADVOCACY, LLC | $36,000 | $131 | $36,131 | $72,270 | Lobbied the Legislature regarding SB 17, SB 790 and AB 265. | #2176502 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Boehringer Ingelheim Pharmaceuticals, Inc. | NORWOOD ASSOCIATES LLC | $24,000 | $730 | $24,730 | $40,837 | Checks from Boehringer Ingelheim USA Corporation. AB 265, 315, 447, 1349; SB 17, 66, 567, 790. | #2174599 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | BRISTOL-MYERS SQUIBB COMPANY | POLITICAL SOLUTIONS, LLC | $71,640 | $834 | $72,474 | $72,474 | AB 265; SB 17, 790 | #2175236 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Cal Capitol Group | TSOU CONSULTING, LLC | $13,500 | $0 | $13,500 | $25,258 | CalDerm:AB 682 AB 443, SB 798, SB 258, AB 1303, SB 351, SB 221, AB 658, SB 17, AB 1612, AB 265, AB 401, SB 487, SB 790, AB 1153, SB 798 American College of Physicians CA Chapter - SB 790 | #2168355 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CALIFORNIA ASSOCIATION OF HEALTH PLANS | LANG HANSEN O'MALLEY AND MILLER GOVERNMENTAL RELATIONS | $45,000 | $0 | $45,000 | $90,000 | AB 205; AB 251; AB 265; AB 315; AB 595; AB 1601; SB 17; SB 171; SB 172; SB 399; SB 538; SB 562 | #2174597 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | California Chronic Care Coalition | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $9,000 | $10 | $9,010 | $15,010 | Legislature:AB154, AB182 AB265, AB1353, SB17, SB641,SB172, SB374, SB419 | #2176382 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | California Life Sciences Association | Gonzalez Government Consulting | $24,000 | — | $24,000 | $42,000 | Bills lobbied: AB 29, AB 182, AB 186, AB 207, AB 315, AB 265, AB 447, AB 479, AB 602, AB 613, AB 845, AB 889, AB 1512, ACA 4, SB 17, SB 97, SB 327, SB 419, SB 567. SB 790. | #2177259 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CALIFORNIA LIFE SCIENCES ASSOCIATION (CLSA) | CARPENTER SIEVERS LLC | $46,000 | $2,348 | $48,348 | $71,423 | AB 29, 43, 182, 186, 207, 315, 265, 444, 447, 479, 602,613, 845, 889, 1107, 1386, 1512; ACA 4; ACR 11, 14; HR 21; SB 17, 23, 66, 327, 419, 440, 567, 790; SCR 27, 29; SR 15, 34, 37 | #2176130 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | California Rheumatology Alliance | KL GOVERNMENT AFFAIRS | $12,900 | $0 | $12,900 | $25,800 | AB 1353, AB 265, AB 315, SB 300 | #2183333 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | California Society of Dermatology | CAL CAPITOL GROUP | $13,500 | $0 | $13,500 | $27,000 | AB 265; 401; 443; 658; 682; 1303; 1612 SB 17; 221; 258; 351; 487; 790; 798; | #2175684 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Capitol Advocacy LLC | ROCHE DIAGNOSTICS | $27,500 | $0 | $27,500 | $27,500 | Legislature: AB 265; AB 444; AB 602; SB 43; SB 212; SB 327. | #2171616 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Capitol Advocacy LLC | BIO (BIOTECHNOLOGY INDUSTRY ORGANIZATION) | $36,000 | $131 | $36,131 | $72,270 | Legislature: AB 265; SB 17; SB 790. | #2171326 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CAPITOL ADVOCACY, LLC ON BEHALF OF UNITED HEALTHCARE | WEST COAST ADVISORS | $20,000 | $0 | $20,000 | $25,000 | AB 29, 156, 157, 182, 265, 315, 401, 532, 587, 715, 904, 1353, 1512; SB 17, 43, 133, 134, 221, 315, 419, 437, 443, 476, 510, 528, 608, 641 | #2174718 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CELGENE CORPORATION | HAWKINS STRATEGIC ADVOCACY | $18,000 | $0 | $18,000 | $42,000 | AB 265; SB 17, 212, 790 | #2173186 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Clear Advocacy LLC | Sanofi US Services Inc. and sanofi pasteur | $13,750 | $0 | $13,750 | $27,500 | Legislature: AB 265; SB 17; SB 790. | #2172359 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CLEAR ADVOCACY, LLC (ON BEHALF OF SANOFI US SERVICES, INC) | JK PEDROTTI, INC. GOV'T RELATIONS | $13,750 | $0 | $13,750 | $27,500 | AB 265; SB 17, 790 | #2174696 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Consumer Federation of California | HERNANDEZ STRATEGY GROUP | $13,590 | $0 | $13,590 | $27,180 | Legislature: AB 87, 103, 165, 168, 175, 243, 265, 314, 375, 380, 413, 502, 550, 611, 713, 726 ,814, 853, 859, 889,940, 965, 1054, 1056, 1070, 1108, 1185, 1255, 1429, 1127, 1526, 1575 ,1679; | #2172081 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | COVERMYMEDS | GOVERNMENTAL ADVOCATES, INC. | $15,000 | $0 | $15,000 | $35,000 | AB 265; Dept of Health Care Services RE: prescription drug prior authorization | #2171551 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CVS HEALTH | JK PEDROTTI, INC. GOV'T RELATIONS | $16,667 | $0 | $16,667 | $41,667 | AB 40, 113, 265, 315, 444, 514, 1560, 1589; SB 212, 244; LEGISLATURE RE: BUDGET | #2174696 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Daiichi Sankyo | ACKLER & ASSOCIATES | $17,400 | $0 | $17,400 | $34,800 | AB 265 AB 1512 SB 17 SB 790 | #2172645 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Endo | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $15,000 | $0 | $15,000 | $23,000 | Legislature: AB29, AB265, AB315, AB1512, SB17, SB790 | #2176382 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $27,000 | $368 | $27,368 | $63,582 | AB 265; SB 17, 567, 790 | #2176109 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | GlaxoSmithKline | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $30,000 | $0 | $30,000 | $52,500 | Legislature: AB29, AB265, AB315, AB889, SB562, SB17, Affinity update & progress HIV/AIDS data sharing with Medi-Cal health plans | #2176382 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Gonzalez Government Consulting | Plasma Protein Therapeutics Association | $12,000 | $0 | $12,000 | $17,000 | Bills lobbied: AB 265, AB 613, SB 17, SB 790. Department of Health Care Services - Outpatient Drug Reimbursement Rule - Blood Factors. | #2177193 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | GREENWICH BIOSCIENCES, INC. | GOVERNMENTAL ADVOCATES, INC. | $22,500 | $0 | $22,500 | $45,000 | AB 845,265,SB 17 | #2171551 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Grifols Shared Services North America, Inc. | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $25,000 | $403 | $25,403 | $35,472 | Legislature: AB29, AB265, AB315, AB613, SB17 | #2176382 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Helyne Meshar & Associates | MANTELL & ASSOCIATES; MAXINE | $1,250 | $0 | $1,250 | $2,250 | AB 265, AB 806, SB 17, AB 550, SB 171, AB 205, SB 6, SB 54, SB 31, SB 149, SB 3, SB 2, AB 210, SB 239, AB 1505, SB 219, SB 649, AB 569, SB 309, SB 562, AB 1137, AB 1199, AB 1578, AB 485, AB 1250, | #2173873 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | HEMOPHILIA COUNCIL OF CALIFORNIA | COWGER & ASSOCIATES | $13,200 | $0 | $13,200 | $39,600 | STATE BUDGET: MEDI-CAL CCS GHPP CCS REDESIGN MEDI-CAL PHARMACY FUNDING ISSUE PER FEDERAL CMS RULING SB 152 AB 613 SCR 33 AB 265 | #2176682 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $11,262 | $412 | $11,674 | $17,969 | AB 265, 1512; SB 17, 327, 567, 790 | #2176109 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | kaleo | CAPITOL ADVOCACY, LLC | $22,500 | $0 | $22,500 | $45,000 | Lobbied the Legislature regarding AB 265 and SB 17. | #2176502 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | MALLINCKRODT, LLC | NOTEWARE GOVERNMENT RELATIONS | $24,000 | $0 | $24,000 | $42,000 | AB 265, AB 1512, SB 17, SB 790 | #2169554 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Matt Back Government Relations | AMGEN | $28,500 | $0 | $28,500 | $47,500 | Legislature: AB 265; AB 444; SB 17; SB 349; SB 790. | #2171628 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $109 | $23,734 | $55,315 | Legislature, Governor's Office re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 419, 443, 567 and Opioid Abuse Policy | #2169977 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $0 | $0 | $0 | $26,324 | AB 265; SB 17, 790 | #2176109 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Noteware Government Relations | UCB INC. | $10,000 | $0 | $10,000 | $10,000 | Legislature: AB 265; SB 17; SB 790. | #2172328 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | NOVARTIS SERVICES, INC. | GOVERNMENTAL ADVOCATES, INC. | $40,000 | $0 | $40,000 | $60,000 | AB 265,SB 17,790 | #2171551 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | NOVO NORDISK, INC. | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $22,000 | $159 | $22,159 | $33,166 | AB 265; SB 17, 790 | #2176109 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. | KAHN CONSULTING; CHRIS | $12,000 | $0 | $12,000 | $24,000 | CALIFORNIA STATE LEGISLATURE REGARDING: AB 265, AB 587, SB 8, SB 17, SB 212. | #2173958 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | PFIZER, INC. | KAHN CONSULTING; CHRIS | $48,000 | $0 | $48,000 | $96,000 | CALIFORNIA STATE LEGISLATURE REGARDING: SB 17, SB 212, SB 419, SB 790, AB 265, AB 587, AB 715, AB 1353, AB 1512. | #2173958 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PUBLIC POLICY ADVOCATES, LLC | $27,500 | $529 | $28,029 | $55,830 | AB 29, 265, 315 | #2173437 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $39,250 | $0 | $39,250 | $79,011 | LEGISLATURE // AB29 AB265 AB1512 SB17 SB790 | #2169471 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | NOTEWARE GOVERNMENT RELATIONS | $46,750 | $0 | $46,750 | $83,027 | AB 265, AB 715, AB 1386, AB 1512; SB 17, SB 790 | #2169554 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Plasma Protein Therapeutics Association | Gonzalez Government Consulting | $12,000 | $0 | $12,000 | $17,000 | Agencies/Bills lobbied: AB 265, AB 613, SB 17, SB 790. Dep0artment of Health Care Services: Outpatient Drug Reimbursement Rule - Blood Factors. | #2177259 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | PLATINUM ADVISORS, LLC obo ALLERGAN | TOPP STRATEGIES | $3,000 | $0 | $3,000 | $12,000 | AB 265; SB 17, 790 | #2174868 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Roche Diagnostics Corporation | CAPITOL ADVOCACY, LLC | $27,500 | $0 | $27,500 | $27,500 | Lobbied the Legislature regarding AB 265, AB 444, AB 602, SB 43, SB 212 and SB 327. | #2176502 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | SANOFI US SERVICES INC. | CLEAR ADVOCACY, LLC | $13,750 | $0 | $13,750 | $27,500 | AB 265; SB 17, 790 | #2174676 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Sunovion Pharmaceuticals, Inc. | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $15,000 | $18 | $15,018 | $35,497 | Legislature: AB29, AB265, AB315, AB444, AB532, SB17, SB562, SB790 | #2176382 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Takeda Pharmaceuticals America | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $13,215 | $249 | $13,464 | $23,209 | Legislature: AB29, AB265, AB315, SB17, SB562, SB790 | #2176382 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | UCB, INC. | NOTEWARE GOVERNMENT RELATIONS | $10,000 | $0 | $10,000 | $10,000 | AB 265; SB 17, SB 790 | #2169554 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | VERTEX PHARMACEUTICALS INCORPORATED | TOPP STRATEGIES | $6,000 | $0 | $6,000 | $24,000 | AB 265; SB 17, 790; SR 34 | #2174868 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Wilke Fleury Hoffelt Gould & Birney LLP | SUNOVION PHARMACEUTICALS INC. | $15,000 | $18 | $15,018 | $35,497 | Legislature: AB 29; AB 265; AB 315; AB 444; AB 532; SB 17; SB 562; SB 790. | #2172333 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | 880 PHARMACY INC | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $27,000 | $4 | $27,004 | $27,004 | AB 265, 315, 612 | #2157665 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Ackler & Associates | DAIICHI SANKYO INC. | $17,400 | $0 | $17,400 | $17,400 | Legislature: AB 265 and AB 1512. | #2153053 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES CALIFORNIA PEOPLE | CAPELL & ASSOCIATES | $6,000 | $0 | $6,000 | $6,000 | AB 156, 157, 180, 205, 207, 265, 391, 595, 1240, 1258, 1353; SB 17, 133, 134, 152, 171, 199, 202, 220, 223, 349, 487, 562, 575, 762; LEGISLATURE, GOVERNOR'S OFFICE, COVERED CA RE: HEALTH REFORM | #2155876 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | AMGEN | Matt Back Government Relations | $19,000 | $0 | $19,000 | $19,000 | Lobbied the Legislature regarding AB 265, AB 315, AB 444, AB 587, SB 17, SB 567 and SB 790. | #2152096 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Astellas Pharma US, Inc. | MANATT, PHELPS & PHILLIPS, LLP | $36,000 | $41 | $36,041 | $36,041 | AB 29, AB 315, AB 265, AB 587, AB 1107, AB 1512, SB 17, SB 462, SB 790 | #2157850 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | AstraZeneca Pharmaceuticals LP | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $65,000 | $0 | $65,000 | $65,000 | Legislature: AB265, AB1107, SB17 | #2157498 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | BAYER U.S., INC. | NOTEWARE GOVERNMENT RELATIONS | $0 | $0 | $3,535 | $3,535 | AB 9, AB 265, SB 17, SB 602 | #2151401 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | BIOCOM | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $25,500 | $0 | $25,500 | $25,500 | AB 182, 265, 444, 602; SB 17, 212, 790; LEGISLATURE RE: OPENING OF BIOCOM OFFICE IN LOS ANGELES | #2156400 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Biotechnology Innovation Organization | CAPITOL ADVOCACY, LLC | $36,000 | $139 | $36,139 | $36,139 | Lobbied the Legislature regarding AB 265, AB 444, AB 587, SB 17 and SB 212. | #2157558 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Boehringer Ingelheim Pharmaceuticals, Inc. | NORWOOD ASSOCIATES LLC | $16,000 | $107 | $16,107 | $16,107 | Checks from Boehringer Ingelheim USA Corporation. AB 265, SB 17, SB 66, SB 567, SB 790. State Legislature re: resolution on diabetes and cardiovascular disease. | #2158242 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | California Association of Physician Groups | Gonzalez Government Consulting | $35,000 | $0 | $35,000 | $35,000 | Bills lobbied: AB 595, AB 156, AB 157, AB 180, AB 265, AB 315, AB 387, AB 1643. SB 172, SB 239, SB 538, SB 562, SB 17, SB 133, SB 134, SB 199, SB 790. | #2157996 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | California Chronic Care Coalition | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $6,000 | $0 | $6,000 | $6,000 | Legislature: AB265, AB1353, SB17, SB641 | #2157498 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | California Life Sciences Association | Gonzalez Government Consulting | $18,000 | — | $18,000 | $18,000 | Bills lobbied: AB 29, AB 182, AB 186, AB 207, AB 315, AB 265, AB 477, AB 479, AB 602, AB 613, AB 845, AB 889, AB 1512, ACA 4, SB 17, SB 327, SB 419, SB 567. | #2157996 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CALIFORNIA LIFE SCIENCES ASSOCIATION (CLSA) | CARPENTER SIEVERS LLC | $23,000 | $75 | $23,075 | $23,075 | AB 29, 43, 182, 186, 207, 315, 265, 444, 447, 479, 602, 613, 845, 889, 1512; ACA 4; ACR 11, 14; HR 8, 21; SB 17, 23, 66, 212, 327, 419, 440, 567; SCR 27, 29; SR 15 | #2156604 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | California Professional Firefighters | CAPITOL CONNECTION | $93,801 | $0 | $93,801 | $93,801 | AB 54, AB 61, AB 71, AB 77, AB 78, AB 89, AB 151, AB 198, AB 199, AB 206, AB 211, AB 216, AB 221, AB 225, AB 252, AB 263, AB 265, AB 281, AB 283, AB 292, AB 315, AB 316, AB 362, AB 387, AB 425 | #2156836 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | California Rheumatology Alliance | KL GOVERNMENT AFFAIRS | $12,900 | $0 | $12,900 | $12,900 | AB 1353, AB 265, AB 315, SB 300 | #2153747 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Capitol Advocacy LLC | BIO (BIOTECHNOLOGY INDUSTRY ORGANIZATION) | $36,000 | $139 | $36,139 | $36,139 | Legislature: AB 265; AB 444; AB 587; SB 17; SB 212. | #2153626 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CAPITOL ADVOCACY, LLC ON BEHALF OF UNITED HEALTHCARE | WEST COAST ADVISORS | $5,000 | $0 | $5,000 | $5,000 | AB 29, 156, 157, 182, 265, 315, 401, 479, 532, 587, 715, 904, 1353, 1512; SB 17, 43, 133, 134, 221, 315, 419, 437, 443, 476, 510, 528, 608, 641 | #2156553 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CELGENE CORPORATION | HAWKINS STRATEGIC ADVOCACY | $24,000 | $0 | $24,000 | $24,000 | AB 29, 265, 1107, 1353; SB 17, 212 | #2152505 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Clear Advocacy LLC | Sanofi US Services Inc. and sanofi pasteur | $13,750 | $0 | $13,750 | $13,750 | Legislature: AB 265; AB 444; AB 1532; SB 17; SB 212; SB 790. | #2155154 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CLEAR ADVOCACY, LLC (ON BEHALF OF SANOFI US SERVICES, INC) | JK PEDROTTI, INC. GOV'T RELATIONS | $13,750 | $0 | $13,750 | $13,750 | AB 265, 444, 1532; SB 17, 212, 790 | #2156584 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Consumer Federation of California | HERNANDEZ STRATEGY GROUP | $13,590 | $0 | $13,590 | $13,590 | Legislature: AB 87, 165, 168, 175, 265, 314, 375, 380, 413, 502, 550, 611, 713, 726, 814, 853, 859, 889, 940, 965, 1054, 1056, 1070, 1108, 1185, 1255, | #2156070 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | COWGER & ASSOCIATES | HEMOPHILIA COUNCIL OF CALIFORNIA | $26,400 | $0 | $26,400 | $26,400 | STATE BUDDGET; MEDI-CAL CCS AND GHPP. CCS REDESIGN. MEDI-CAL PHARMACY ISSUES PER FED CMS RULING. SB 152 AB 613SCR 33 AB 265. | #2157634 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CYSTIC FIBROSIS FOUNDATION | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $9,000 | $195 | $9,195 | $9,195 | AB 265; SB 152 | #2157665 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Daiichi Sankyo | ACKLER & ASSOCIATES | $17,400 | $0 | $17,400 | $17,400 | AB 265 AB 1512 | #2155689 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Endo | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $8,000 | $0 | $8,000 | $8,000 | Legislature: AB29, AB265, AB315, AB1512, SB17 | #2157498 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | GlaxoSmithKline | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $22,500 | $0 | $22,500 | $22,500 | Legislature: AB29, AB265, AB315, SB17 | #2157498 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Gonzalez Government Consulting | Plasma Protein Therapeutics Association | $5,000 | $0 | $5,000 | $5,000 | Bills lobbied: AB 29, AB 265, AB 315, AB 587, AB 613, AB 1488, SB 17, SB 790. Department of Health Care Services - Outpatient Drug Reimbursement Rule - Blood Factors. | #2157936 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Grifols Shared Services North America, Inc. | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $10,000 | $69 | $10,069 | $10,069 | Legislature: AB29, AB265, AB315, AB613, SB17 | #2157498 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | HEMOPHILIA COUNCIL OF CALIFORNIA | COWGER & ASSOCIATES | $26,400 | $0 | $26,400 | $26,400 | STATE BUDGET: MEDI-CAL CCS AND GHPP; CCS REDESIGN; MEDI-CAL PHARMACY ISSUE PER FED CMS RULING SB 152 AB 613 AB 265 SCR 33 | #2157598 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | kaleo | CAPITOL ADVOCACY, LLC | $22,500 | $0 | $22,500 | $22,500 | Lobbied the Legislature regarding AB 265 and SB 17. | #2157558 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | MALLINCKRODT, LLC | NOTEWARE GOVERNMENT RELATIONS | $18,000 | $0 | $18,000 | $18,000 | AB 265, AB 1512, SB 17 | #2151401 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Matt Back Government Relations | AMGEN | $19,000 | $0 | $19,000 | $19,000 | Legislature: AB 265; AB 315; AB 444; AB 587; SB 17; SB 567; SB 790. | #2154242 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $31,500 | $81 | $31,581 | $31,581 | Legislature re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 176, 212, 419, 443 | #2156067 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $26,324 | $0 | $26,324 | $26,324 | AB 265, 315; SB 17 | #2157665 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Noteware Government Relations | UCB INC. | $0 | $0 | $0 | $0 | Legislature: AB 265 and SB 17. | #2154238 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | NOVARTIS SERVICES, INC. | GOVERNMENTAL ADVOCATES, INC. | $20,000 | $0 | $20,000 | $20,000 | AB 444, 265, 587; SB 17, 212, 562, 567 | #2156876 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | NOVO NORDISK, INC. | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $11,000 | $7 | $11,007 | $11,007 | AB 265, 315; SB 17 | #2157665 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. | KAHN CONSULTING; CHRIS | $12,000 | $0 | $12,000 | $12,000 | CALIFORNIA STATE LEGISLATURE REGARDING: AB 265, AB 587, SB 8, SB 17, SB 212. | #2156391 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | PFIZER, INC. | KAHN CONSULTING; CHRIS | $48,000 | $0 | $48,000 | $48,000 | CALIFORNIA STATE LEGISLATURE REGARDING: SB 17, SB 212, SB 419, AB 265, AB 587, AB 1353, AB 1512. | #2156391 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $39,250 | $511 | $39,761 | $39,761 | AB265 AB315 AB1512 SB17 | #2151784 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | NOTEWARE GOVERNMENT RELATIONS | $31,167 | $5,110 | $36,277 | $36,277 | AB 265, SB 17 | #2151401 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Plasma Protein Therapeutics Association | Gonzalez Government Consulting | $5,000 | $0 | $5,000 | $5,000 | AB 29, AB 265, AB 315, AB 587, AB 613, AB 1488, SB 17, SB 790. | #2157996 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | SANOFI US SERVICES INC. | CLEAR ADVOCACY, LLC | $13,750 | $0 | $13,750 | $13,750 | AB 265, 444, 1532; SB 17, 212, 790 | #2156570 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Sunovion Pharmaceuticals, Inc. | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $20,000 | $479 | $20,479 | $20,479 | Legislature: AB29, AB265, AB315 | #2157498 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Takeda Pharmaceuticals America | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $9,645 | $100 | $9,745 | $9,745 | Legislature: AB29, AB265, AB315, SB17 | #2157498 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | UCB, INC. | NOTEWARE GOVERNMENT RELATIONS | $0 | $0 | $0 | $0 | AB 265, SB 17 | #2151401 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Wilke Fleury Hoffelt Gould & Birney LLP | SUNOVION PHARMACEUTICALS INC. | $20,000 | $479 | $20,479 | $20,479 | Legislature: AB 29; AB 265; AB 315. | #2153039 |